Sorgente - Conservazione Cellule Staminali
Centro assistenza clienti

I nostri trapianti

Oltre 3.000 campioni rilasciati per trapianto

Conservazione cellule staminali bambini

Il miglior indice di qualità per una banca di conservazione del sangue cordonale è l’aver reso possibile l’esecuzione di trapianti con i campioni conservati nei propri laboratori per tanti anni. La maggior parte delle banche attive non ha effettuato alcun trapianto e quindi non offre alcuna garanzia concreta della qualità dei propri processi di conservazione.

La nostra banca del cordone ombelicale è leader in Europa per numero di campioni rilasciati per trapianto. Inoltre il 100% dei trapianti effettuati con campioni conservati dalla nostra biobanca è andato a buon fine.
Affidati alla biobanca Leader in Europa per tasso di trapianti – Il nostro contributo concreto alla vita.

Lp.FonteFonte di celluleDiagnosiAmbito medicoAnno di applicazioneTipo di terapiaNazioneEtà del paziente
1cord bloodautologoucerebral palsyneurology2020experimental therapyPoland2
2cord bloodallogeneic - familytalassemiahematology2019standard therapyTurkey6
3cord bloodallogeneic - familytalassemia majorhematology2019standard therapyTurkey5
4cord bloodautologouautismneurology2019experimental therapyPoland3
5cord bloodallogeneic - familytalassemiahematology2019standard therapyTurkey6
6cord bloodallogeneic - familytalassemia majorhematology2019standard therapyTurkey3
7cord bloodallogeneic - familytalassemia majorhematology2019standard therapyTurkey12
8cord bloodallogeneic - familycerebral palsyneurology2019experimental therapyPoland4
9cord bloodallogeneic - familycerebral palsyneurology2019experimental therapyPoland8
10cord bloodautologousevere aplastic anaemiahematology2019standard therapyPortugal4
11cord bloodallogeneic - familyFanconi anemiahematology2019standard therapyTurkey12
12cord bloodautologouautismneurology2019experimental therapyPoland10
13cord bloodautologouaplastic anaemiahematology2018standard therapyPoland3
14cord bloodallogeneic - familytalassemia majorhematology2018standard therapyTurkey9
15cord bloodallogeneic - familytalassemia majorhematology2018standard therapyTurkey4
16cord bloodallogeneic - familytalassemia majorhematology2018standard therapyTurkey4
17cord bloodallogeneic - familyautismneurology2018experimental therapyPoland3
18cord bloodallogeneic - familytalassemia majorhematology2018standard therapyTurkey5
19cord bloodallogeneic - familytalassemia majorhematology2018standard therapyTurkey10
20cord bloodallogeneic - familysickle cell anemiahematology2018standard therapyTurkey10
21cord bloodautologoucerebral palsyneurology2018experimental therapyPoland1
22cord bloodautologouautismneurology2018experimental therapyPortugal6
23cord bloodautologouautismneurology2018experimental therapyPortugal8
24cord bloodallogeneic - familyCD40 ligand deficiencyhematology2017standard therapyTurkey9
25cord bloodallogeneic - familytalassemia majorhematology2017standard therapyTurkey4
26cord bloodallogeneic - familytalassemia majorhematology2017standard therapyTurkey4
27cord bloodautologoucerebral palsyneurology2017experimental therapyPoland2
28cord bloodautologoucerebral palsyneurology2017experimental therapyPoland5
29cord bloodautologoucerebral palsyneurology2017experimental therapyPoland10
30cord bloodautologoucerebral palsyneurology2017experimental therapySpain7
31cord bloodautologouautismneurology2017experimental therapyPoland4
32cord bloodallogeneic - familyrelapse of acute lymphoblastic leukemiahematology2017standard therapyPoland7
33cord bloodautologoucerebral palsyneurology2017experimental therapyPoland6
34cord bloodautologouautismneurology2017experimental therapyPoland6
35cord bloodautologouautismneurology2017experimental therapyPoland7
36cord bloodautologouautismneurology2017experimental therapyPoland5
37cord bloodautologouautismneurology2017experimental therapyPoland4
38cord bloodautologouautismneurology2017experimental therapyPoland4
39cord bloodallogeneic - familychronic granulomatous diseasehematology2017standard therapyTurkey3
40cord bloodautologouautismneurology2016experimental therapyPoland6
41cord bloodallogeneic - familyacute lymphoblastic leukemiahematology2016standard therapyHungary7
42cord bloodallogeneicacute myeloid leukemiahematology2016standard therapyPoland6
43cord bloodallogeneic - familyacute lymphoblastic leukemiahematology2015standard therapyPoland4
44cord bloodallogeneic - familyacute lymphoblastic leukemiahematology2014standard therapyTurkey7
45cord bloodautologoucerebral palsyneurology2014experimental therapyPortugal4
46cord bloodallogeneicacute lymphoblastic leukemiahematology2014standard therapySpain4
47cord bloodautologouacute myeloid leukemiahematology2014standard therapyPortugal6
48cord bloodallogeneic - familyaplastic anaemiahematology2013standard therapyPoland3
49cord bloodallogeneic - familyacute myeloid leukemiahematology2013standard therapyPoland3
50cord bloodallogeneic - familybeta-talassemia, agranulocytosishematology2013standard therapyTurkey8
51cord bloodallogeneic - familyX - linked lymphoproliferative syndromehematology2013standard therapyPoland0
52cord bloodallogeneic - familysevere aplastic anaemiahematology2012standard therapyHungary3
53cord bloodallogeneic - familyanaemia, talassemia majorhematology2012standard therapyTurkey6
54cord bloodallogeneic - familytalassemia major, acute lymphoblastic leukemiahematology2012standard therapyTurkey3
55cord bloodallogeneic - familyT-acute lymphoblastic leukemiahematology2012standard therapyTurkey5
56cord bloodautologoucerebral palsyneurology2012experimental therapyPortugal3
57cord bloodallogeneic - familyFanconi anemiahematology2011standard therapyPoland12
58cord bloodallogeneic - familyacute myeloid leukemiahematology2011standard therapyHungary2
59cord bloodallogeneic - familyacute lymphoblastic leukemiahematology2011standard therapyPoland5
60cord bloodallogeneic - familyhistiocytosihematology2011standard therapyPoland2
61cord bloodallogeneic - familychronic granulomatous diseasehematology2011standard therapyPoland7
62cord bloodautologoucerebral palsyneurology2011experimental therapyPortugal6
63cord bloodallogeneic - familypre -B acute lymphoblastic leukemiahematology2010standard therapyHungary1
64cord bloodautologoucerebral palsyneurology2010experimental therapyPortugal1
65cord bloodautologoucerebral palsyneurology2010experimental therapyPortugal1
66cord bloodautologoucerebral palsyneurology2010experimental therapyPortugal6
67cord bloodallogeneic - familymyelodysplastic syndromehematology2009standard therapyPoland5
68cord bloodautologoucerebral palsyneurology2009experimental therapyPortugal2
69cord bloodautologoucerebral palsyneurology2009experimental therapyPortugal2
70cord bloodallogeneic - familyacute lymphoblastic leukemiahematology2008standard therapyPoland5
71cord bloodautologoucerebral ischemianeurology2008experimental therapyPoland1
72cord bloodallogeneic - familyneuroblastomahematology2007standard therapyPoland8
73cord bloodallogeneic - familySCID, severe combined immunodeficiencyhematology2007standard therapyPortugal1
74placental bloodautologoucerebral palsyneurology2020experimental therapyPoland2
75cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2020experimental therapyPoland53
76cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2020experimental therapyPoland54
77cord tissue (Wharton's jelly)allogeneicmyelomeningocele, Arnold-Chiari malformationneurology2020experimental therapyPoland2
78cord tissue (Wharton's jelly)allogeneicmyelomeningocele, hydrocephalusneurology2020experimental therapyPoland2
79cord tissue (Wharton's jelly)allogeneicautismneurology2020experimental therapyPoland4
80cord tissue (Wharton's jelly)allogeneicalopecia areatadermatology2020experimental therapyPoland36
81cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2020experimental therapyPoland40
82cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2020experimental therapyPoland17
83cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2020experimental therapyPoland48
84cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2020experimental therapyPoland61
85cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2020experimental therapyPoland62
86cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous system, congenital genetic defectneurology2020experimental therapyPoland2
87cord tissue (Wharton's jelly)allogeneicmyelomeningoceleneurology2020experimental therapyPoland8
88cord tissue (Wharton's jelly)allogeneicdisorder of brain, unspecified - adrenoleukodystrophyneurology2020experimental therapyPoland11
89cord tissue (Wharton's jelly)allogeneichypoxic encephalopathy, drug-resistant epilepsyneurology2020experimental therapyPoland20
90cord tissue (Wharton's jelly)allogeneicother sphingolipidose, Krabbe's leukodystrophyneurology2020experimental therapyPoland4
91cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2020experimental therapyPoland37
92cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2020experimental therapyPoland64
93cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2020experimental therapyPoland6
94cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2020experimental therapyPoland62
95cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2020experimental therapyPoland6
96cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2020experimental therapyPoland62
97cord tissue (Wharton's jelly)allogeneicacquired epileptic aphasianeurology2020experimental therapyPoland4
98cord tissue (Wharton's jelly)allogeneicstate after encephalitineurology2020experimental therapyPoland3
99cord tissue (Wharton's jelly)allogeneicautismneurology2020experimental therapyPoland7
100cord tissue (Wharton's jelly)allogeneicbone marrow transplant rejectionhematology2020experimental therapyPoland14
101cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2020experimental therapyPoland9
102cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2020experimental therapyPoland5
103cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous system - global development delay and microcephalyneurology2020experimental therapyPoland2
104cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2020experimental therapyPoland6
105cord tissue (Wharton's jelly)allogeneichypoxic-ischemic encephalopathyneurology2020experimental therapyPoland2
106cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2020experimental therapyPoland60
107cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2020experimental therapyPoland73
108cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2020experimental therapyPoland33
109cord tissue (Wharton's jelly)allogeneicpolyneuropathyneurology2020experimental therapyPoland43
110cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2020experimental therapyPoland16
111cord tissue (Wharton's jelly)allogeneicother spinal muscular atrophy and related syndrome, bulbar palsyneurology2020experimental therapyPolandno data
112cord tissue (Wharton's jelly)allogeneicmacular degenerationophthalmology2020experimental therapyPoland20
113cord tissue (Wharton's jelly)allogeneiccovid-19, severe pneumonia, acute respiratory failurepulmonology2020experimental therapyPoland59
114cord tissue (Wharton's jelly)allogeneictransplantation failure, coexisting viral infectionshematology2020experimental therapyPoland13
115cord tissue (Wharton's jelly)allogeneiccovid-19pulmonology2020experimental therapyPoland74
116cord tissue (Wharton's jelly)allogeneicacute respiratory distress syndrome, covid-19pulmonology2020experimental therapyPoland53
117cord tissue (Wharton's jelly)allogeneicepidermolysis bullosadermatology2020experimental therapyPoland35
118cord tissue (Wharton's jelly)allogeneiccovid-19pulmonology2020experimental therapyPoland76
119cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2020experimental therapyPoland63
120cord tissue (Wharton's jelly)allogeneicosteoarthritiorthopedic2020experimental therapyPoland56
121cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2020experimental therapyPoland69
122cord tissue (Wharton's jelly)allogeneicacute respiratory distress syndrome, covid-19pulmonology2020experimental therapyPoland66
123cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2020experimental therapyPoland60
124cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2020experimental therapyPoland64
125cord tissue (Wharton's jelly)allogeneicchondromalaciaorthopedic2020experimental therapyPoland61
126cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2020experimental therapyPoland8
127cord tissue (Wharton's jelly)allogeneicepilepsia, encephalopathy, developmental delayneurology2020experimental therapyPoland7
128cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland6
129cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland9
130cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland0
131cord tissue (Wharton's jelly)allogeneicencephalopathy, epilepsy,neurology2019experimental therapyPoland17
132cord tissue (Wharton's jelly)allogeneicdelayed psychomotor development, Chiari malformationneurology2019experimental therapyPoland4
133cord tissue (Wharton's jelly)allogeneicepilepsia, encephalopathyneurology2019experimental therapyPoland8
134cord tissue (Wharton's jelly)allogeneicmicrocephalia, cerebellar syndrome, delayed psychomotor developmentneurology2019experimental therapyPoland7
135cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland3
136cord tissue (Wharton's jelly)allogeneicspina bifida, epilepsyneurology2019experimental therapyPoland2
137cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland3
138cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland11
139cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2019experimental therapyPoland39
140cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland5
141cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland54
142cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland58
143cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland65
144cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland60
145cord tissue (Wharton's jelly)allogeneicoptic neuropathyophthalmology2019experimental therapyPoland26
146cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2019experimental therapyPoland19
147cord tissue (Wharton's jelly)allogeneicatrophy of the optic nerveophthalmology2019experimental therapyPoland38
148cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2019experimental therapyPoland43
149cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2019experimental therapyPoland68
150cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2019experimental therapyPoland35
151cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2019experimental therapyPoland72
152cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2019experimental therapyPoland33
153cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2019experimental therapyPoland21
154cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2019experimental therapyPoland26
155cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2019experimental therapyPoland23
156cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2019experimental therapyPoland35
157cord tissue (Wharton's jelly)allogeneic - familycoxarthrosisorthopedic2019experimental therapyPoland57
158cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2019clinical trialSwedenno data
159cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2019clinical trialSwedenno data
160cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland2
161cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland4
162cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2019experimental therapyPoland30
163cord tissue (Wharton's jelly)allogeneicencephalopathyneurology2019experimental therapyPoland7
164cord tissue (Wharton's jelly)allogeneichypoxia-ischemic encephalopathyneurology2019experimental therapyPoland2
165cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland38
166cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland61
167cord tissue (Wharton's jelly)allogeneiccerebral palsy, Wolf-Hirschhorn syndromeneurology2019experimental therapyPoland10
168cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2019experimental therapyPoland3
169cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland3
170cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2019experimental therapyPoland3
171cord tissue (Wharton's jelly)allogeneicencephalopathy, epilepsy, delayed psychomotor developmentneurology2019experimental therapyPoland13
172cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland11
173cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland70
174cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland3
175cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2019experimental therapyPoland5
176cord tissue (Wharton's jelly)allogeneicspinal muscular atrophyneurology2019experimental therapyPoland11
177cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland7
178cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland3
179cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2019experimental therapyPoland5
180cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland9
181cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2019experimental therapyPoland46
182cord tissue (Wharton's jelly)allogeneicnon-adhesion left tibia shank fracture, neurofibromatosis t. Iorthopedic2019experimental therapyPoland18
183cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2019experimental therapyPoland62
184cord tissue (Wharton's jelly)allogeneicAsperger syndromeneurology2019experimental therapyPoland10
185cord tissue (Wharton's jelly)allogeneic - familycerebral palsyneurology2019experimental therapyPoland4
186cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2019experimental therapyPoland10
187cord tissue (Wharton's jelly)allogeneicDandy-Walker malformation, trisomy 9neurology2019experimental therapyPoland10
188cord tissue (Wharton's jelly)allogeneicepilepsia, developmental delayneurology2019experimental therapyPoland9
189cord tissue (Wharton's jelly)allogeneiccerebellar ataxianeurology2019experimental therapyPoland50
190cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2019experimental therapyPoland40
191cord tissue (Wharton's jelly)allogeneiccondition after sympathetic inflammation of the left eyeophthalmology2019experimental therapyPoland23
192cord tissue (Wharton's jelly)allogeneicsecondary progressive multiple sclerosineurology2019experimental therapyPoland22
193cord tissue (Wharton's jelly)allogeneicchronic graft versus host diseasehematology2019experimental therapyPoland10
194cord tissue (Wharton's jelly)allogeneicbirth asphyxianeurology2019experimental therapyPoland5
195cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland2
196cord tissue (Wharton's jelly)allogeneicdelayed psychomotor development, epilepsianeurology2019experimental therapyPoland2
197cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland6
198cord tissue (Wharton's jelly)allogeneicencephalopathy, epilepsy,neurology2019experimental therapyPoland3
199cord tissue (Wharton's jelly)allogeneicoptic neuropathyophthalmology2019experimental therapyPoland71
200cord tissue (Wharton's jelly)allogeneicother vascular and retinal disorderophthalmology2019experimental therapyPoland34
201cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2019experimental therapyPoland40
202cord tissue (Wharton's jelly)allogeneicspinal cord injuryneurology2019experimental therapyPoland33
203cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2019clinical trialSwedenno data
204cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2019clinical trialSwedenno data
205cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2019clinical trialSwedenno data
206cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2019clinical trialSwedenno data
207cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2019clinical trialSwedenno data
208cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2019clinical trialSwedenno data
209cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2019clinical trialSwedenno data
210cord tissue (Wharton's jelly)allogeneic - familysclerosis multiplexneurology2019experimental therapyPoland61
211cord tissue (Wharton's jelly)allogeneicepilepsia, developmental delayneurology2019experimental therapyPoland3
212cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland4
213cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2019experimental therapyPoland67
214cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2019experimental therapyPoland38
215cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2019experimental therapyPolandno data
216cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland73
217cord tissue (Wharton's jelly)allogeneicsecondary progressive multiple sclerosineurology2019experimental therapyPoland64
218cord tissue (Wharton's jelly)allogeneicsecondary progressive multiple sclerosineurology2019experimental therapyPoland54
219cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland58
220cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland7
221cord tissue (Wharton's jelly)allogeneic - familycerebral palsyneurology2019experimental therapyPoland2
222cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland1
223cord tissue (Wharton's jelly)allogeneicmyelomeningoceleneurology2019experimental therapyPoland2
224cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2019experimental therapyPoland7
225cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland15
226cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland8
227cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland2
228cord tissue (Wharton's jelly)allogeneicstatus after meningitis and encephaliti, encephalopathyneurology2019experimental therapyPoland4
229cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland6
230cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland9
231cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland65
232cord tissue (Wharton's jelly)allogeneicAngelman syndrome, cerebral palsyneurology2019experimental therapyPoland13
233cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland4
234cord tissue (Wharton's jelly)allogeneicFriedreich's ataxianeurology2019experimental therapyPoland59
235cord tissue (Wharton's jelly)allogeneiccerebral palsy, Dandy-Walker malformationneurology2019experimental therapyPoland7
236cord tissue (Wharton's jelly)allogeneiccerebral palsy, developmental delayneurology2019experimental therapyPoland18
237cord tissue (Wharton's jelly)allogeneicdelayed psychomotor development, congenital cytomegalyneurology2019experimental therapyPoland8
238cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2019experimental therapyPoland1
239cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2019experimental therapyPoland61
240cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland6
241cord tissue (Wharton's jelly)allogeneicKrabbe diseaseneurology2019experimental therapyPoland3
242cord tissue (Wharton's jelly)allogeneicencephalopathyneurology2019experimental therapyPoland7
243cord tissue (Wharton's jelly)allogeneicchoroirodermiaophthalmology2019experimental therapyPoland24
244cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland7
245cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsy, microcephalianeurology2019experimental therapyPoland9
246cord tissue (Wharton's jelly)allogeneicoptic neuropathyophthalmology2019experimental therapyPoland49
247cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2019experimental therapyPoland24
248cord tissue (Wharton's jelly)allogeneicischemic strokeneurology2019experimental therapyPoland40
249cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland39
250cord tissue (Wharton's jelly)allogeneicmacular degenerationophthalmology2019experimental therapyPoland15
251cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2019experimental therapyPoland59
252cord tissue (Wharton's jelly)allogeneicgeneral hypotonianeurology2019experimental therapyPoland2
253cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland5
254cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2019experimental therapyPoland5
255cord tissue (Wharton's jelly)allogeneicencephalopathy, global developmental delayneurology2019experimental therapyPoland4
256cord tissue (Wharton's jelly)allogeneicarthrosis of the knee joint, chondromalaciaorthopedic2019experimental therapyPoland51
257cord tissue (Wharton's jelly)allogeneicdegeneration of the cartilage of the knee jointorthopedic2019experimental therapyPoland44
258cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland46
259cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland9
260cord tissue (Wharton's jelly)allogeneic - familyencephalopathy, cerebral palsyneurology2019experimental therapyPoland6
261cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland59
262cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2019clinical trialSwedenno data
263cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland61
264cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland2
265cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland1
266cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland5
267cord tissue (Wharton's jelly)allogeneicmyelomeningoceleneurology2019experimental therapyPoland19
268cord tissue (Wharton's jelly)allogeneicBest diseaseophthalmology2019experimental therapyPoland56
269cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland22
270cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland28
271cord tissue (Wharton's jelly)allogeneicencephalopathy, global developmental delayneurology2019experimental therapyPoland5
272cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland11
273cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland7
274cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland4
275cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2019experimental therapyPoland6
276cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2019experimental therapyPoland2
277cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland66
278cord tissue (Wharton's jelly)allogeneicprogressive supranuclear atrophyneurology2019experimental therapyPoland62
279cord tissue (Wharton's jelly)allogeneicpolineuropathyneurology2019experimental therapyPoland60
280cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland13
281cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland5
282cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland2
283cord tissue (Wharton's jelly)allogeneicparoxysmal dystonianeurology2019experimental therapyPoland3
284cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous systemneurology2019experimental therapyPoland1
285cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland44
286cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2019experimental therapyPoland12
287cord tissue (Wharton's jelly)allogeneiccerebral palsy, hydrocephalusneurology2019experimental therapyPoland2
288cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland9
289cord tissue (Wharton's jelly)allogeneic - familycerebral palsyneurology2019experimental therapyPoland10
290cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2019experimental therapyPoland8
291cord tissue (Wharton's jelly)allogeneiccerebral palsy, hydrocephalu, epilepsyneurology2019experimental therapyPoland3
292cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland65
293cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2019experimental therapyPoland9
294cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland8
295cord tissue (Wharton's jelly)allogeneicglobal developmental delayneurology2019experimental therapyPoland6
296cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland6
297cord tissue (Wharton's jelly)allogeneicautism, microcephalianeurology2019experimental therapyPoland7
298cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland7
299cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland10
300cord tissue (Wharton's jelly)allogeneicchoroirodermiaophthalmology2019experimental therapyPoland30
301cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2019experimental therapyPoland10
302cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland7
303cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland3
304cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland65
305cord tissue (Wharton's jelly)allogeneicother disorders of the central nervous system, genetic defect, suspected autismneurology2019experimental therapyPoland6
306cord tissue (Wharton's jelly)allogeneicother disorders of the central nervous system, genetic defect, suspected autismneurology2019experimental therapyPoland6
307cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland7
308cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland14
309cord tissue (Wharton's jelly)allogeneicspinal cord injuryneurology2019experimental therapyPoland27
310cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2019experimental therapyPoland70
311cord tissue (Wharton's jelly)allogeneicchondrocalcinosi, moderate gonarthrosisorthopedic2019experimental therapyPoland79
312cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2019experimental therapyPoland2
313cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland8
314cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland41
315cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland6
316cord tissue (Wharton's jelly)allogeneicother disorders of the optic discneurology2019experimental therapyPoland3
317cord tissue (Wharton's jelly)allogeneicagenesis of corpus callosum, atrophy of the optic nervesneurology2019experimental therapyPoland7
318cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2019experimental therapyPoland18
319cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2019experimental therapyPoland41
320cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland52
321cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2019experimental therapyPoland78
322cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland6
323cord tissue (Wharton's jelly)allogeneic - familyautismneurology2019experimental therapyPoland4
324cord tissue (Wharton's jelly)allogeneicarthrogryposis multiplex congenita, myopathyneurology2019experimental therapyPoland3
325cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland59
326cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland32
327cord tissue (Wharton's jelly)allogeneicepilepsianeurology2019experimental therapyPoland8
328cord tissue (Wharton's jelly)allogeneicfragile X syndrome, pervasive developmental disorderneurology2019experimental therapyPoland4
329cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous systemneurology2019experimental therapyPoland4
330cord tissue (Wharton's jelly)allogeneicischemic strokeneurology2019experimental therapyPolandno data
331cord tissue (Wharton's jelly)allogeneicDravet's syndromeneurology2019experimental therapyPoland19
332cord tissue (Wharton's jelly)allogeneicsecondary progressive multiple sclerosineurology2019experimental therapyPoland59
333cord tissue (Wharton's jelly)allogeneicalopecia areatadermatology2019experimental therapyPoland47
334cord tissue (Wharton's jelly)allogeneicalopecia areatadermatology2019experimental therapyPoland57
335cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland2
336cord tissue (Wharton's jelly)allogeneicpropionic acidurianeurology2019experimental therapyPoland10
337cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland56
338cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland61
339cord tissue (Wharton's jelly)allogeneicencephalopathy, global developmental delayneurology2019experimental therapyPoland7
340cord tissue (Wharton's jelly)allogeneicencephalopathy, global developmental delayneurology2019experimental therapyPoland7
341cord tissue (Wharton's jelly)allogeneiccondition after bilateral optic nerve inflammationophthalmology2019experimental therapyPoland46
342cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland49
343cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland67
344cord tissue (Wharton's jelly)allogeneicmultiple system atrophyneurology2019experimental therapyPoland54
345cord tissue (Wharton's jelly)allogeneichypoxia-ischemic encephalopathyneurology2019experimental therapyPoland2
346cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2019experimental therapyPoland5
347cord tissue (Wharton's jelly)allogeneicdegenerative disease of the spineorthopedic2019experimental therapyPoland86
348cord tissue (Wharton's jelly)allogeneicmyelomeningoceleneurology2019experimental therapyPoland2
349cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2019experimental therapyPoland0
350cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland6
351cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous systemneurology2019experimental therapyPoland0
352cord tissue (Wharton's jelly)allogeneichypoxia-ischemic encephalopathyneurology2019experimental therapyPoland4
353cord tissue (Wharton's jelly)allogeneiclimb-girdle muscular dystrophyneurology2019experimental therapyPoland5
354cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2019experimental therapyPoland34
355cord tissue (Wharton's jelly)allogeneicspinal cord injuryneurology2019experimental therapyPoland26
356cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2019experimental therapyPoland59
357cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland7
358cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland7
359cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2019experimental therapyPoland0
360cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2019experimental therapyPoland26
361cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2019experimental therapyPoland63
362cord tissue (Wharton's jelly)allogeneicmultiple system atrophyneurology2019experimental therapyPoland71
363cord tissue (Wharton's jelly)allogeneicepilepsianeurology2019experimental therapyPoland13
364cord tissue (Wharton's jelly)allogeneiccerebral palsy, hydrocephalusneurology2019experimental therapyPoland4
365cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2019experimental therapyPoland6
366cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland6
367cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2019experimental therapyPoland5
368cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland59
369cord tissue (Wharton's jelly)allogeneic - familyautismneurology2019experimental therapyPoland7
370cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland16
371cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland4
372cord tissue (Wharton's jelly)allogeneic - familydystrophia progressiva pseudohypertrophica /DMDneurology2019experimental therapyPoland15
373cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland5
374cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland4
375cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2019experimental therapyPoland15
376cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland3
377cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland9
378cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2019experimental therapyPoland37
379cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2019experimental therapyPoland17
380cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland6
381cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland3
382cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland3
383cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsy, developmental delayneurology2019experimental therapyPoland1
384cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2019experimental therapyPoland38
385cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland5
386cord tissue (Wharton's jelly)allogeneicepileptic encephalopathy, epilepsyneurology2019experimental therapyPoland16
387cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2019experimental therapyPoland54
388cord tissue (Wharton's jelly)allogeneiccerebellar syndrome, multiple system atrophyneurology2019experimental therapyPoland57
389cord tissue (Wharton's jelly)allogeneicalopecia areatadermatology2019experimental therapyPoland43
390cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2019experimental therapyPoland53
391cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2019experimental therapyPoland84
392cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPolandno data
393cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland5
394cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland5
395cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2019experimental therapyPoland48
396cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2019experimental therapyPoland34
397cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2019experimental therapyPoland63
398cord tissue (Wharton's jelly)allogeneichyperacute graft versus host desease, condition after bone marrow transplantation due to severe congenital neutropeniahematology2019experimental therapyPoland0
399cord tissue (Wharton's jelly)allogeneicchronic graft versus host desease, condition after bone marrow transplantation due to severe aplastic anemiahematology2019experimental therapyPoland9
400cord tissue (Wharton's jelly)allogeneicParkinson syndromeneurology2019experimental therapyPoland51
401cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous systemneurology2019experimental therapyPoland3
402cord tissue (Wharton's jelly)allogeneic - familycerebral palsyneurology2019experimental therapyPoland3
403cord tissue (Wharton's jelly)allogeneic - familycerebral palsyneurology2019experimental therapyPoland3
404cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland3
405cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland11
406cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2019experimental therapyPoland69
407cord tissue (Wharton's jelly)allogeneicepidermolysis bullosadermatology2019experimental therapyPoland51
408cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2019experimental therapyPoland27
409cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2019experimental therapyPoland37
410cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2019experimental therapyPoland64
411cord tissue (Wharton's jelly)allogeneicchondromalaciaorthopedic2019experimental therapyPoland60
412cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2019experimental therapyPoland5
413cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2019experimental therapyPoland10
414cord tissue (Wharton's jelly)allogeneiccerebral palsy, autismneurology2019experimental therapyPoland5
415cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2019experimental therapyPoland6
416cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2019experimental therapyPoland41
417cord tissue (Wharton's jelly)allogeneiccerebellar ataxianeurology2019experimental therapyPoland37
418cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPolandno data
419cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland57
420cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous systemneurology2019experimental therapyPoland3
421cord tissue (Wharton's jelly)allogeneicepileptic encephalopathy, epilepsyneurology2019experimental therapyPoland2
422cord tissue (Wharton's jelly)allogeneicencephalopathy, epilepsy, delayed psychomotor developmentneurology2019experimental therapyPoland2
423cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2019experimental therapyPoland3
424cord tissue (Wharton's jelly)allogeneicmyelomeningoceleneurology2019experimental therapyPoland1
425cord tissue (Wharton's jelly)allogeneicautism, diabetes mellitus t. 1neurology2019experimental therapyPoland8
426cord tissue (Wharton's jelly)allogeneicmyelomeningoceleneurology2019experimental therapyPoland4
427cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2019experimental therapyPoland12
428cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland7
429cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland8
430cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2019experimental therapyPoland13
431cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland7
432cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland8
433cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland9
434cord tissue (Wharton's jelly)allogeneicautismneurology2019experimental therapyPoland12
435cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland62
436cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2019experimental therapyPoland67
437cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland68
438cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland31
439cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland25
440cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland36
441cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland61
442cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland16
443cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2018experimental therapyPoland44
444cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2018experimental therapyPoland3
445cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2018experimental therapyPoland59
446cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland48
447cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland44
448cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland52
449cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2018experimental therapyPoland2
450cord tissue (Wharton's jelly)allogeneicmyopathyneurology2018experimental therapyPoland57
451cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2018experimental therapyPoland28
452cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2018experimental therapyPoland66
453cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland67
454cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous systemneurology2018experimental therapyPoland1
455cord tissue (Wharton's jelly)allogeneicdegeneration of the cartilage of the knee jointorthopedic2018experimental therapyPoland34
456cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland41
457cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland32
458cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland46
459cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2018experimental therapyPoland39
460cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland55
461cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland36
462cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland34
463cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland27
464cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2018experimental therapyPoland3
465cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2018experimental therapyPoland33
466cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland52
467cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland66
468cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland47
469cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland59
470cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland50
471cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland51
472cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland38
473cord tissue (Wharton's jelly)allogeneicdevelopmental delayneurology2018experimental therapyPoland14
474cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland46
475cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland38
476cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2018experimental therapyPoland30
477cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland65
478cord tissue (Wharton's jelly)allogeneicepilepsianeurology2018experimental therapyPoland20
479cord tissue (Wharton's jelly)allogeneicage-related macular degenerationophthalmology2018experimental therapyPoland46
480cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland30
481cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2018experimental therapyPoland44
482cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland34
483cord tissue (Wharton's jelly)allogeneicage-related macular degenerationophthalmology2018experimental therapyPoland20
484cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland55
485cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2018experimental therapyPoland9
486cord tissue (Wharton's jelly)allogeneicstrokeneurology2018experimental therapyPoland70
487cord tissue (Wharton's jelly)allogeneicFriedreich's ataxianeurology2018experimental therapyPoland27
488cord tissue (Wharton's jelly)allogeneicFriedreich's ataxianeurology2018experimental therapyPoland31
489cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2018experimental therapyPoland46
490cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland47
491cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland52
492cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland28
493cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland3
494cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland8
495cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland62
496cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2018experimental therapyPoland21
497cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland40
498cord tissue (Wharton's jelly)allogeneicdevelopmental delayneurology2018experimental therapyPoland7
499cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland9
500cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland2
501cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland8
502cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland6
503cord tissue (Wharton's jelly)allogeneicencephalopathyneurology2018experimental therapyPoland54
504cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland54
505cord tissue (Wharton's jelly)allogeneicdamage to the intercondylar fissure of the right kneeorthopedic2018experimental therapyPoland40
506cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2018experimental therapyPoland7
507cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland67
508cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland41
509cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland35
510cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland83
511cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland57
512cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland57
513cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland45
514cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland28
515cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland61
516cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland20
517cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2018experimental therapyPoland34
518cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland75
519cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland4
520cord tissue (Wharton's jelly)allogeneicdystrophia myotonicaneurology2018experimental therapyPoland27
521cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland80
522cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2018experimental therapyPoland2
523cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland9
524cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland76
525cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland54
526cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland35
527cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland80
528cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2018experimental therapyPoland25
529cord tissue (Wharton's jelly)allogeneicholoprosencephalianeurology2018experimental therapyPoland12
530cord tissue (Wharton's jelly)allogeneicdystrophia progressiva pseudohypertrophica /DMDneurology2018experimental therapyPoland8
531cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2018experimental therapyPoland22
532cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland65
533cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland65
534cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland60
535cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland31
536cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland40
537cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland70
538cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland9
539cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous systemneurology2018experimental therapyPoland1
540cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2018experimental therapyPoland10
541cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland64
542cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland47
543cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland66
544cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2018experimental therapyPolandno data
545cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland75
546cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2018experimental therapyPoland4
547cord tissue (Wharton's jelly)allogeneicencephalopathy, cerebral palsyneurology2018experimental therapyPoland22
548cord tissue (Wharton's jelly)allogeneic - family + allogeneiccerebral palsyneurology2018experimental therapyPoland13
549cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland2
550cord tissue (Wharton's jelly)allogeneicdelayed psychomotor developmentneurology2018experimental therapyPoland6
551cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland67
552cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland62
553cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland38
554cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland44
555cord tissue (Wharton's jelly)allogeneicstrokeneurology2018experimental therapyPoland53
556cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland3
557cord tissue (Wharton's jelly)allogeneicother reduction deformities of brain, schizencephalyneurology2018experimental therapyPoland5
558cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland49
559cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland4
560cord tissue (Wharton's jelly)allogeneicarthrogryposis multiplex congenita, epilepsianeurology2018experimental therapyPoland6
561cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland64
562cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland63
563cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland5
564cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2018experimental therapyPoland39
565cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2018experimental therapyPoland47
566cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland67
567cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland64
568cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2018experimental therapyPoland25
569cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland6
570cord tissue (Wharton's jelly)allogeneicepilepsianeurology2018experimental therapyPoland13
571cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland7
572cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland11
573cord tissue (Wharton's jelly)allogeneicdelayed psychomotor development, atrophy of the optic nervesneurology2018experimental therapyPoland2
574cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous systemneurology2018experimental therapyPoland16
575cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland5
576cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2018experimental therapyPoland28
577cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland62
578cord tissue (Wharton's jelly)allogeneiclack of expected normal physical development, unspecifiedneurology2018experimental therapyPoland10
579cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland8
580cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2018experimental therapyPoland66
581cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland3
582cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland11
583cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland3
584cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland3
585cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2018experimental therapyPoland34
586cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland55
587cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous systemneurology2018experimental therapyPoland5
588cord tissue (Wharton's jelly)allogeneicstrokeneurology2018experimental therapyPoland67
589cord tissue (Wharton's jelly)allogeneicmicrocephalianeurology2018experimental therapyPoland12
590cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland2
591cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2018experimental therapyPoland48
592cord tissue (Wharton's jelly)allogeneicgeneral hypotonianeurology2018experimental therapyPoland2
593cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland4
594cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2018experimental therapyPoland4
595cord tissue (Wharton's jelly)allogeneicdelayed psychomotor developmentneurology2018experimental therapyPoland5
596cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland5
597cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland6
598cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland6
599cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland16
600cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland55
601cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland48
602cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland2
603cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland4
604cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland5
605cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland2
606cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland8
607cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland27
608cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland47
609cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland44
610cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland42
611cord tissue (Wharton's jelly)allogeneicstate after encephaliti, epilepsyneurology2018experimental therapyPoland44
612cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2018experimental therapyPoland29
613cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland64
614cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland38
615cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous systemneurology2018experimental therapyPoland6
616cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous systemneurology2018experimental therapyPoland0
617cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland4
618cord tissue (Wharton's jelly)allogeneicencephalopathy, epilepsyneurology2018experimental therapyPoland21
619cord tissue (Wharton's jelly)allogeneicWolf-Hirschhorn syndromeneurology2018experimental therapyPoland1
620cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland5
621cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland7
622cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland38
623cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2018experimental therapyPoland1
624cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland2
625cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland2
626cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2018experimental therapyPoland2
627cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland85
628cord tissue (Wharton's jelly)allogeneicbrain disorder, unspecifiedneurology2018experimental therapyPoland10
629cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2018experimental therapyPoland18
630cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland69
631cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland23
632cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland50
633cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland37
634cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland61
635cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2018experimental therapyPoland1
636cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland6
637cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland5
638cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland70
639cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland66
640cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland1
641cord tissue (Wharton's jelly)allogeneicdegeneration of the cartilage of the knee jointorthopedic2018experimental therapyPoland57
642cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2018experimental therapyPoland7
643cord tissue (Wharton's jelly)allogeneicepilepsianeurology2018experimental therapyPoland7
644cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsy, developmental delayneurology2018experimental therapyPoland8
645cord tissue (Wharton's jelly)allogeneicgeneral hypotonianeurology2018experimental therapyPoland9
646cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland4
647cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland64
648cord tissue (Wharton's jelly)allogeneictetraparesis spasticaneurology2018experimental therapyPoland12
649cord tissue (Wharton's jelly)allogeneicencephalopathyneurology2018experimental therapyPoland11
650cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland56
651cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2018experimental therapyPoland58
652cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland11
653cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland8
654cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland7
655cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland22
656cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland69
657cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland71
658cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2018experimental therapyPoland21
659cord tissue (Wharton's jelly)allogeneicvisual pathway dysfunctionophthalmology2018experimental therapyPoland48
660cord tissue (Wharton's jelly)allogeneicage-related macular degenerationophthalmology2018experimental therapyPoland82
661cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland7
662cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland64
663cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland1
664cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2018experimental therapyPoland3
665cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland5
666cord tissue (Wharton's jelly)allogeneicgeneral hypotonianeurology2018experimental therapyPoland7
667cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2018experimental therapyPoland26
668cord tissue (Wharton's jelly)allogeneicdelayed psychomotor developmentneurology2018experimental therapyPoland4
669cord tissue (Wharton's jelly)allogeneicdelayed psychomotor developmentneurology2018experimental therapyPoland7
670cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland68
671cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland78
672cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland8
673cord tissue (Wharton's jelly)allogeneiccerebral palsy, encephalopathyneurology2018experimental therapyPoland1
674cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland51
675cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2018experimental therapyPoland18
676cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland70
677cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland12
678cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2018experimental therapyPoland1
679cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland4
680cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland0
681cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland8
682cord tissue (Wharton's jelly)allogeneicencephalopathyneurology2018experimental therapyPoland24
683cord tissue (Wharton's jelly)allogeneicPhelan-McDermid Syndromeneurology2018experimental therapyPoland17
684cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland6
685cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous systemneurology2018experimental therapyPoland4
686cord tissue (Wharton's jelly)allogeneicbilateral edema of the optic nerveophthalmology2018experimental therapyPoland12
687cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland62
688cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2018experimental therapyPoland43
689cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2018experimental therapyPoland3
690cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland2
691cord tissue (Wharton's jelly)allogeneicstrokeneurology2018experimental therapyPoland42
692cord tissue (Wharton's jelly)allogeneicepilepsianeurology2018experimental therapyPoland4
693cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous systemneurology2018experimental therapyPoland1
694cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous systemneurology2018experimental therapyPoland2
695cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland15
696cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland6
697cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland13
698cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2018experimental therapyPoland1
699cord tissue (Wharton's jelly)allogeneiccerebellar syndrome, delayed psychomotor developmentneurology2018experimental therapyPoland3
700cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland3
701cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland61
702cord tissue (Wharton's jelly)allogeneicepilepsianeurology2018experimental therapyPoland3
703cord tissue (Wharton's jelly)allogeneicstrokeneurology2018experimental therapyPoland60
704cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland78
705cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland7
706cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland40
707cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland41
708cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2018experimental therapyPoland48
709cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2018experimental therapyPoland2
710cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland9
711cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland6
712cord tissue (Wharton's jelly)allogeneic - familyautism, congenital cytomegalyneurology2018experimental therapyPoland6
713cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland9
714cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland3
715cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland6
716cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland4
717cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland7
718cord tissue (Wharton's jelly)allogeneictetraparesisorthopedic2018experimental therapyPoland32
719cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland38
720cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2018experimental therapyPoland22
721cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland50
722cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland5
723cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2018experimental therapyPoland2
724cord tissue (Wharton's jelly)allogeneicparalysineurology2018experimental therapyPoland14
725cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland30
726cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland5
727cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2018experimental therapyPoland66
728cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland73
729cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland30
730cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2018experimental therapyPoland42
731cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland7
732cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland2
733cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland1
734cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2018experimental therapyPoland2
735cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2018experimental therapyPoland8
736cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland6
737cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland49
738cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland7
739cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland2
740cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland6
741cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2018experimental therapyPoland2
742cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland49
743cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland62
744cord tissue (Wharton's jelly)allogeneicmultiple system atrophyneurology2018experimental therapyPoland47
745cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
746cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
747cord tissue (Wharton's jelly)allogeneicprogressive supranuclear atrophyneurology2018experimental therapyPoland62
748cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland13
749cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland7
750cord tissue (Wharton's jelly)allogeneicneuropathyneurology2018experimental therapyPoland47
751cord tissue (Wharton's jelly)allogeneicFriedreich's ataxianeurology2018experimental therapyPoland22
752cord tissue (Wharton's jelly)allogeneicmultiple system atrophyneurology2018experimental therapyPoland61
753cord tissue (Wharton's jelly)allogeneicmyelomeningoceleneurology2018experimental therapyPoland1
754cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland1
755cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous system- Pitt Hopkins syndromeneurology2018experimental therapyPoland10
756cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland16
757cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland44
758cord tissue (Wharton's jelly)allogeneicleukodystrophyneurology2018experimental therapyPoland5
759cord tissue (Wharton's jelly)allogeneicleukodystrophyneurology2018experimental therapyPoland7
760cord tissue (Wharton's jelly)allogeneiccongenital myasthenianeurology2018experimental therapyPoland6
761cord tissue (Wharton's jelly)allogeneiccongenital myasthenianeurology2018experimental therapyPoland3
762cord tissue (Wharton's jelly)allogeneicepilepsia, agenesis corporis callosineurology2018experimental therapyPoland2
763cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland5
764cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2018experimental therapyPoland4
765cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland34
766cord tissue (Wharton's jelly)allogeneicoptic neuropathyophthalmology2018experimental therapyPoland15
767cord tissue (Wharton's jelly)allogeneicatrophy of the optic nerveophthalmology2018experimental therapyPoland18
768cord tissue (Wharton's jelly)allogeneicLeber's hereditary optic neuropathyophthalmology2018experimental therapyPoland18
769cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2018experimental therapyPoland3
770cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
771cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2018experimental therapyPoland34
772cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland6
773cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland12
774cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland33
775cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland46
776cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2018experimental therapyPoland39
777cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland53
778cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland56
779cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland54
780cord tissue (Wharton's jelly)allogeneicdevelopmental delayneurology2018experimental therapyPoland5
781cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland15
782cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2018experimental therapyPoland10
783cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2018experimental therapyPoland38
784cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland42
785cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland44
786cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland3
787cord tissue (Wharton's jelly)allogeneic - familycerebral palsyneurology2018experimental therapyPoland10
788cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland6
789cord tissue (Wharton's jelly)allogeneicgeneral hypotonia, autismneurology2018experimental therapyPoland8
790cord tissue (Wharton's jelly)allogeneicgenetic syndrome - deletion of part of chromosome 3neurology2018experimental therapyPoland8
791cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland2
792cord tissue (Wharton's jelly)allogeneicautismneurology2018experimental therapyPoland8
793cord tissue (Wharton's jelly)allogeneicdelayed psychomotor development, epilepsianeurology2018experimental therapyPoland4
794cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland5
795cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland54
796cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland6
797cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2018experimental therapyPoland64
798cord tissue (Wharton's jelly)allogeneicmyelomeningocele, hydrocephalusneurology2018experimental therapyPoland2
799cord tissue (Wharton's jelly)allogeneicdelayed psychomotor developmentneurology2018experimental therapyPoland4
800cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous system - syndrom Pierre-Robinneurology2018experimental therapyPoland2
801cord tissue (Wharton's jelly)allogeneiccartilage damageorthopedic2018experimental therapyPoland56
802cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2018experimental therapyPoland2
803cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2018experimental therapyPoland9
804cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland60
805cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2018experimental therapyPoland36
806cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland42
807cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2018experimental therapyPoland52
808cord tissue (Wharton's jelly)allogeneicautism, delayed psychomotor developmentneurology2018experimental therapyPoland6
809cord tissue (Wharton's jelly)allogeneic - familyautismneurology2018experimental therapyPoland4
810cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2018experimental therapyPoland1
811cord tissue (Wharton's jelly)allogeneicdelayed psychomotor developmentneurology2018experimental therapyPoland4
812cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2018experimental therapyPoland55
813cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
814cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
815cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
816cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
817cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
818cord tissue (Wharton's jelly)allogeneicdiabetes mellitus t. 1endocrinology2018clinical trialSwedenno data
819cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland67
820cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland37
821cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland71
822cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPolandno data
823cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland7
824cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland47
825cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2017experimental therapyPoland44
826cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2017experimental therapyPoland34
827cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland58
828cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland49
829cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2017experimental therapyPoland37
830cord tissue (Wharton's jelly)allogeneicdystrophia myotonicaneurology2017experimental therapyPoland37
831cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2017experimental therapyPoland26
832cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland56
833cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland48
834cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland46
835cord tissue (Wharton's jelly)allogeneiccartilage damageorthopedic2017experimental therapyPoland61
836cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2017experimental therapyPoland34
837cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2017experimental therapyPoland52
838cord tissue (Wharton's jelly)allogeneicatrophy of the optic nerveophthalmology2017experimental therapyPoland23
839cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2017experimental therapyPoland31
840cord tissue (Wharton's jelly)allogeneicage-related macular degenerationophthalmology2017experimental therapyPoland33
841cord tissue (Wharton's jelly)allogeneictetraparesis spasticaneurology2017experimental therapyPoland29
842cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2017experimental therapyPoland24
843cord tissue (Wharton's jelly)allogeneicspinal muscular atrophyneurology2017experimental therapyPoland10
844cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2017experimental therapyPoland30
845cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland56
846cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland65
847cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland45
848cord tissue (Wharton's jelly)allogeneicdystrophia progressiva pseudohypertrophica /DMDneurology2017experimental therapyPoland28
849cord tissue (Wharton's jelly)allogeneiclimb-girdle muscular dystrophyneurology2017experimental therapyPoland44
850cord tissue (Wharton's jelly)allogeneicspinal muscular atrophyneurology2017experimental therapyPoland41
851cord tissue (Wharton's jelly)allogeneiclimb-girdle muscular dystrophyneurology2017experimental therapyPoland25
852cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland75
853cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2017experimental therapyPoland23
854cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland43
855cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2017experimental therapyPoland39
856cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland51
857cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2017experimental therapyPoland39
858cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland42
859cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2017experimental therapyPoland30
860cord tissue (Wharton's jelly)allogeneicspinal muscular atrophyneurology2017experimental therapyPoland12
861cord tissue (Wharton's jelly)allogeneicspinal muscular atrophyneurology2017experimental therapyPoland8
862cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2017experimental therapyPoland58
863cord tissue (Wharton's jelly)allogeneiccri du chat syndromeneurology2017experimental therapyPoland8
864cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland18
865cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland59
866cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2017experimental therapyPoland22
867cord tissue (Wharton's jelly)allogeneicdystrophia progressiva pseudohypertrophica /DMDneurology2017experimental therapyPoland28
868cord tissue (Wharton's jelly)allogeneicepilepsianeurology2017experimental therapyPoland3
869cord tissue (Wharton's jelly)allogeneiccranium bifidumneurology2017experimental therapyPoland5
870cord tissue (Wharton's jelly)allogeneictransverse myelitineurology2017experimental therapyPoland8
871cord tissue (Wharton's jelly)allogeneicsyringomielianeurology2017experimental therapyPoland42
872cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland64
873cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2017experimental therapyPoland47
874cord tissue (Wharton's jelly)allogeneiclimb-girdle muscular dystrophyneurology2017experimental therapyPoland38
875cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland56
876cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland13
877cord tissue (Wharton's jelly)allogeneicencephalopathyneurology2017experimental therapyPoland21
878cord tissue (Wharton's jelly)allogeneicencephalopathyneurology2017experimental therapyPoland5
879cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland41
880cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland52
881cord tissue (Wharton's jelly)allogeneiccerebral palsy, neonatal cerebral leukomalacianeurology2017experimental therapyPoland1
882cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland11
883cord tissue (Wharton's jelly)allogeneiclimb-girdle muscular dystrophyneurology2017experimental therapyPoland26
884cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland9
885cord tissue (Wharton's jelly)allogeneiccerebellar syndromeneurology2017experimental therapyPoland11
886cord tissue (Wharton's jelly)allogeneiccongenital fiber-type disproportion myopathyneurology2017experimental therapyPoland1
887cord tissue (Wharton's jelly)allogeneicchronic myeloid leukemiahematology2017experimental therapyPoland5
888cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland61
889cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland40
890cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland48
891cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland1
892cord tissue (Wharton's jelly)allogeneiclimb-girdle muscular dystrophyneurology2017experimental therapyPoland37
893cord tissue (Wharton's jelly)allogeneicarthrogryposis multiplex congenitaneurology2017experimental therapyPoland1
894cord tissue (Wharton's jelly)allogeneicencephalopathy, cerebral palsyneurology2017experimental therapyPoland4
895cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2017experimental therapyPoland5
896cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2017experimental therapyPoland6
897cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland15
898cord tissue (Wharton's jelly)allogeneictraumatic brain injuryneurology2017experimental therapyPoland9
899cord tissue (Wharton's jelly)allogeneicno bone adhesionorthopedic2017experimental therapyPoland14
900cord tissue (Wharton's jelly)allogeneicno bone adhesionorthopedic2017experimental therapyPoland17
901cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland69
902cord tissue (Wharton's jelly)allogeneicspinal muscular atrophyneurology2017experimental therapyPoland24
903cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2017experimental therapyPoland37
904cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland31
905cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland52
906cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2017experimental therapyPoland27
907cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2017experimental therapyPoland45
908cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2017experimental therapyPoland34
909cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2017experimental therapyPoland31
910cord tissue (Wharton's jelly)allogeneichydrocephalu, neonatal cerebral leukomalacianeurology2017experimental therapyPoland2
911cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland6
912cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland7
913cord tissue (Wharton's jelly)allogeneicdelayed psychomotor developmentneurology2017experimental therapyPoland3
914cord tissue (Wharton's jelly)allogeneicdelayed psychomotor developmentneurology2017experimental therapyPoland6
915cord tissue (Wharton's jelly)allogeneicsyndrom IFAPhematology2017experimental therapyPoland3
916cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland52
917cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2017experimental therapyPoland13
918cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2017experimental therapyPoland11
919cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2017experimental therapyPoland66
920cord tissue (Wharton's jelly)allogeneicischemia within the optic nerveophthalmology2017experimental therapyPoland37
921cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland35
922cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland4
923cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland77
924cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland36
925cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland63
926cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland35
927cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland31
928cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland31
929cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland10
930cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland33
931cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland5
932cord tissue (Wharton's jelly)allogeneic - familycerebral palsyneurology2017experimental therapyPoland12
933cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland5
934cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland3
935cord tissue (Wharton's jelly)allogeneicdelayed psychomotor developmentneurology2017experimental therapyPoland5
936cord tissue (Wharton's jelly)allogeneichypoxia-ischemic encephalopathyneurology2017experimental therapyPoland1
937cord tissue (Wharton's jelly)allogeneicKrabbe diseaseneurology2017experimental therapyPoland6
938cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2017experimental therapyPoland24
939cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland51
940cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland45
941cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2017experimental therapyPoland31
942cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2017experimental therapyPoland48
943cord tissue (Wharton's jelly)allogeneiclimb-girdle muscular dystrophyneurology2017experimental therapyPoland62
944cord tissue (Wharton's jelly)allogeneiccerebellar syndromeneurology2017experimental therapyPoland60
945cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland6
946cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland4
947cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland6
948cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland6
949cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland46
950cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland49
951cord tissue (Wharton's jelly)allogeneiccondition after encephalitineurology2017experimental therapyPoland19
952cord tissue (Wharton's jelly)allogeneiclimb-girdle muscular dystrophyneurology2017experimental therapyPoland35
953cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland1
954cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland6
955cord tissue (Wharton's jelly)allogeneicencephalopathy, cerebral palsyneurology2017experimental therapyPoland1
956cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland7
957cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland13
958cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2017experimental therapyPoland6
959cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2017experimental therapyPoland32
960cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2017experimental therapyPoland46
961cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland54
962cord tissue (Wharton's jelly)allogeneicdystrophia myotonicaneurology2017experimental therapyPoland41
963cord tissue (Wharton's jelly)allogeneicglobal developmental delayneurology2017experimental therapyPoland4
964cord tissue (Wharton's jelly)allogeneicoptic neuropathyophthalmology2017experimental therapyPoland56
965cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland4
966cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland3
967cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2017experimental therapyPoland33
968cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2017experimental therapyPoland42
969cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2017experimental therapyPoland2
970cord tissue (Wharton's jelly)allogeneicoptic neuropathyophthalmology2017experimental therapyPoland30
971cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2017experimental therapyPoland39
972cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland4
973cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland8
974cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland3
975cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland2
976cord tissue (Wharton's jelly)allogeneicdelayed psychomotor developmentneurology2017experimental therapyPoland7
977cord tissue (Wharton's jelly)allogeneicarthrogryposis multiplex congenitaneurology2017experimental therapyPoland3
978cord tissue (Wharton's jelly)allogeneicdystrophia myotonicaneurology2017experimental therapyPoland3
979cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland63
980cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2017experimental therapyPoland76
981cord tissue (Wharton's jelly)allogeneicdystrophia progressiva pseudohypertrophica /BMDneurology2017experimental therapyPoland23
982cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland3
983cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland43
984cord tissue (Wharton's jelly)allogeneicoptic neuropathyophthalmology2017experimental therapyPoland74
985cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland64
986cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland51
987cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland70
988cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland65
989cord tissue (Wharton's jelly)allogeneicencephalopathyneurology2017experimental therapyPoland5
990cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland8
991cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland15
992cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland5
993cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland51
994cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2017experimental therapyPoland12
995cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland26
996cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland18
997cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland10
998cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland13
999cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland7
1000cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland5
1001cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland3
1002cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland3
1003cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland5
1004cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland3
1005cord tissue (Wharton's jelly)allogeneicDevic’s diseaseneurology2017experimental therapyPoland45
1006cord tissue (Wharton's jelly)allogeneiclimb-girdle muscular dystrophyneurology2017experimental therapyPoland31
1007cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland6
1008cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland5
1009cord tissue (Wharton's jelly)allogeneicepilepsia, autismneurology2017experimental therapyPoland6
1010cord tissue (Wharton's jelly)allogeneicmyopathy of congenital fiber type disproportion, damage to the central nervous systemneurology2017experimental therapyPoland2
1011cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland2
1012cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland68
1013cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland59
1014cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland49
1015cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland60
1016cord tissue (Wharton's jelly)allogeneicglobal developmental delayneurology2017experimental therapyPoland7
1017cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland2
1018cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland4
1019cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2017experimental therapyPoland10
1020cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland56
1021cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2017experimental therapyPoland38
1022cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2017experimental therapyPoland25
1023cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland58
1024cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland3
1025cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland4
1026cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland4
1027cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland63
1028cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland62
1029cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland57
1030cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland59
1031cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland46
1032cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland53
1033cord tissue (Wharton's jelly)allogeneicleukodystrophyneurology2017experimental therapyPoland7
1034cord tissue (Wharton's jelly)allogeneicatrophy of the optic nerveophthalmology2017experimental therapyPoland35
1035cord tissue (Wharton's jelly)allogeneicepilepsianeurology2017experimental therapyPoland16
1036cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2017experimental therapyPolandno data
1037cord tissue (Wharton's jelly)allogeneictetraparesisorthopedic2017experimental therapyPoland27
1038cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2017experimental therapyPoland8
1039cord tissue (Wharton's jelly)allogeneicepilepsianeurology2017experimental therapyPoland9
1040cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland4
1041cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland15
1042cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2017experimental therapyPoland3
1043cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland13
1044cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland2
1045cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland55
1046cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2017experimental therapyPoland53
1047cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2017experimental therapyPolandno data
1048cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland3
1049cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland2
1050cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland4
1051cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2017experimental therapyPoland27
1052cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland3
1053cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland4
1054cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2017experimental therapyPoland47
1055cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland65
1056cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland2
1057cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland54
1058cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2017experimental therapyPoland77
1059cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2017experimental therapyPoland30
1060cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland78
1061cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2017experimental therapyPoland33
1062cord tissue (Wharton's jelly)allogeneiccondition after myelitineurology2017experimental therapyPoland34
1063cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland43
1064cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2017experimental therapyPoland22
1065cord tissue (Wharton's jelly)allogeneicdystrophia progressiva pseudohypertrophica /DMDneurology2017experimental therapyPoland9
1066cord tissue (Wharton's jelly)allogeneicdelayed psychomotor development, epilepsianeurology2017experimental therapyPoland11
1067cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland18
1068cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland7
1069cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland6
1070cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland10
1071cord tissue (Wharton's jelly)allogeneicencephalopathyneurology2017experimental therapyPoland1
1072cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2017experimental therapyPoland32
1073cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland4
1074cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland1
1075cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland22
1076cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland44
1077cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland78
1078cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2017experimental therapyPoland37
1079cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2017experimental therapyPoland3
1080cord tissue (Wharton's jelly)allogeneicepilepsianeurology2017experimental therapyPoland12
1081cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland61
1082cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2017experimental therapyPoland65
1083cord tissue (Wharton's jelly)allogeneichypoxia-ischemic encephalopathyneurology2017experimental therapyPoland1
1084cord tissue (Wharton's jelly)allogeneictetraparesis spastica, epilepsianeurology2017experimental therapyPoland2
1085cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland5
1086cord tissue (Wharton's jelly)allogeneicspinal cord injury, tetraparesisorthopedic2017experimental therapyPoland42
1087cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland4
1088cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland11
1089cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland24
1090cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2017experimental therapyPoland38
1091cord tissue (Wharton's jelly)allogeneicdystrophia progressiva pseudohypertrophica /DMDneurology2017experimental therapyPoland14
1092cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland8
1093cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland12
1094cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2017experimental therapyPoland66
1095cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2017experimental therapyPoland85
1096cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous systemneurology2017experimental therapyPoland2
1097cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland60
1098cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland28
1099cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland1
1100cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2017experimental therapyPoland8
1101cord tissue (Wharton's jelly)allogeneiccerebellar syndromeneurology2017experimental therapyPoland52
1102cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2017experimental therapyPoland35
1103cord tissue (Wharton's jelly)allogeneiccerebellar syndromeneurology2017experimental therapyPoland60
1104cord tissue (Wharton's jelly)allogeneiccongenital malformations of the nervous system, unspecifiedneurology2017experimental therapyPoland8
1105cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland10
1106cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland2
1107cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2017experimental therapyPoland24
1108cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2017experimental therapyPoland29
1109cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland78
1110cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland61
1111cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland65
1112cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland10
1113cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland17
1114cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland5
1115cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2017experimental therapyPoland52
1116cord tissue (Wharton's jelly)allogeneiccerebral palsy, epilepsyneurology2017experimental therapyPoland2
1117cord tissue (Wharton's jelly)allogeneicautism, encephalopathyneurology2017experimental therapyPoland7
1118cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland5
1119cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland5
1120cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2017experimental therapyPoland69
1121cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2017experimental therapyPoland64
1122cord tissue (Wharton's jelly)allogeneiccartilage damageorthopedic2017experimental therapyPoland46
1123cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2017experimental therapyPoland37
1124cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland43
1125cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2017experimental therapyPoland59
1126cord tissue (Wharton's jelly)allogeneiccerebellar syndromeneurology2017experimental therapyPoland46
1127cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland2
1128cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland6
1129cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland54
1130cord tissue (Wharton's jelly)allogeneicother specific disorders of the central nervous systemneurology2017experimental therapyPoland2
1131cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland8
1132cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2017experimental therapyPoland7
1133cord tissue (Wharton's jelly)allogeneiccerebellar ataxianeurology2017experimental therapyPoland33
1134cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland36
1135cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland45
1136cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland6
1137cord tissue (Wharton's jelly)allogeneicautismneurology2017experimental therapyPoland7
1138cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland1
1139cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2017experimental therapyPoland7
1140cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2017experimental therapyPoland66
1141cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2017experimental therapyPoland48
1142cord tissue (Wharton's jelly)allogeneicdelayed psychomotor developmentneurology2017experimental therapyPoland8
1143cord tissue (Wharton's jelly)allogeneicepilepsianeurology2017experimental therapyPoland15
1144cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2017experimental therapyPoland14
1145cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland48
1146cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland2
1147cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2017experimental therapyPoland6
1148cord tissue (Wharton's jelly)allogeneicoptic neuropathyophthalmology2017experimental therapyPoland7
1149cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2017experimental therapyPoland0
1150cord tissue (Wharton's jelly)allogeneicmoyamoya diseaseneurology2017experimental therapyPoland17
1151cord tissue (Wharton's jelly)allogeneicanterior ischemic optic neuropathyophthalmology2017experimental therapyPoland67
1152cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2017experimental therapyPoland57
1153cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2017experimental therapyPoland71
1154cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland7
1155cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2016experimental therapyPoland2
1156cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland5
1157cord tissue (Wharton's jelly)allogeneicadrenoleukodystrophyneurology2016experimental therapyPoland11
1158cord tissue (Wharton's jelly)allogeneicadrenoleukodystrophy, encephalopathyneurology2016experimental therapyPoland8
1159cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland10
1160cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland44
1161cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland60
1162cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland32
1163cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2016experimental therapyPoland64
1164cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2016experimental therapyPoland62
1165cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland18
1166cord tissue (Wharton's jelly)allogeneicdystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland48
1167cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland10
1168cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland35
1169cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland53
1170cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland12
1171cord tissue (Wharton's jelly)allogeneicdelayed psychomotor developmentneurology2016experimental therapyPoland3
1172cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2016experimental therapyPoland14
1173cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2016experimental therapyPoland6
1174cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2016experimental therapyPoland65
1175cord tissue (Wharton's jelly)allogeneicleukodystrophyneurology2016experimental therapyPoland2
1176cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland59
1177cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland6
1178cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland2
1179cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland12
1180cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland9
1181cord tissue (Wharton's jelly)allogeneicatrophy of the optic nerveophthalmology2016experimental therapyPoland20
1182cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2016experimental therapyPoland53
1183cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2016experimental therapyPoland33
1184cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2016experimental therapyPoland22
1185cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland10
1186cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland8
1187cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2016experimental therapyPoland29
1188cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland33
1189cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland37
1190cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland39
1191cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland7
1192cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2016experimental therapyPoland28
1193cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2016experimental therapyPoland69
1194cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2016experimental therapyPoland33
1195cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2016experimental therapyPoland20
1196cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2016experimental therapyPoland24
1197cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2016experimental therapyPoland25
1198cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland8
1199cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland39
1200cord tissue (Wharton's jelly)allogeneicpatella cartilage damageorthopedic2016experimental therapyPoland60
1201cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland6
1202cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2016experimental therapyPoland44
1203cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland25
1204cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland10
1205cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland63
1206cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland54
1207cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland53
1208cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland46
1209cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland58
1210cord tissue (Wharton's jelly)allogeneicchronic graft versus host diseasehematology2016experimental therapyPoland19
1211cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland55
1212cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland58
1213cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland61
1214cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland52
1215cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland59
1216cord tissue (Wharton's jelly)allogeneictetraparesis spasticaorthopedic2016experimental therapyPoland28
1217cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland60
1218cord tissue (Wharton's jelly)allogeneicspinal muscular atrophyneurology2016experimental therapyPoland34
1219cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2016experimental therapyPoland69
1220cord tissue (Wharton's jelly)allogeneictetraparesis spasticaorthopedic2016experimental therapyPoland47
1221cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2016experimental therapyPoland18
1222cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland2
1223cord tissue (Wharton's jelly)allogeneictraumatic brain injuryneurology2016experimental therapyPoland54
1224cord tissue (Wharton's jelly)allogeneicepilepsianeurology2016experimental therapyPoland19
1225cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland59
1226cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland66
1227cord tissue (Wharton's jelly)allogeneictetraparesisorthopedic2016experimental therapyPoland27
1228cord tissue (Wharton's jelly)allogeneicepilepsianeurology2016experimental therapyPoland14
1229cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland42
1230cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2016experimental therapyPoland60
1231cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland6
1232cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland11
1233cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland9
1234cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2016experimental therapyPoland49
1235cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2016experimental therapyPoland69
1236cord tissue (Wharton's jelly)allogeneicoptic atrophyophthalmology2016experimental therapyPoland69
1237cord tissue (Wharton's jelly)allogeneicepilepsianeurology2016experimental therapyPoland13
1238cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland45
1239cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland53
1240cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland36
1241cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland59
1242cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland66
1243cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland49
1244cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland55
1245cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland46
1246cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland72
1247cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland54
1248cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland56
1249cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland61
1250cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland64
1251cord tissue (Wharton's jelly)allogeneicmalformation syndromeneurology2016experimental therapyPoland3
1252cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland64
1253cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2016experimental therapyPoland38
1254cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland6
1255cord tissue (Wharton's jelly)allogeneicencephalopathyneurology2016experimental therapyPoland2
1256cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland62
1257cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland56
1258cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland51
1259cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland2
1260cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland4
1261cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2016experimental therapyPoland55
1262cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2016experimental therapyPoland54
1263cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland33
1264cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2016experimental therapyPoland41
1265cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2016experimental therapyPoland49
1266cord tissue (Wharton's jelly)allogeneicchoroideremiaophthalmology2016experimental therapyPoland50
1267cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2016experimental therapyPoland63
1268cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2016experimental therapyPoland7
1269cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland60
1270cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland73
1271cord tissue (Wharton's jelly)allogeneicleukodystrophyneurology2016experimental therapyPoland2
1272cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland61
1273cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2016experimental therapyPoland48
1274cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2016experimental therapyPoland32
1275cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2016experimental therapyPoland3
1276cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2016experimental therapyPoland61
1277cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2016experimental therapyPoland45
1278cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland61
1279cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland79
1280cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland72
1281cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland48
1282cord tissue (Wharton's jelly)allogeneicadrenoleukodystrophyneurology2016experimental therapyPoland6
1283cord tissue (Wharton's jelly)allogeneicadrenoleukodystrophyneurology2016experimental therapyPoland9
1284cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland54
1285cord tissue (Wharton's jelly)allogeneic - family + allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland50
1286cord tissue (Wharton's jelly)allogeneiclimb-girdle muscular dystrophyneurology2016experimental therapyPoland22
1287cord tissue (Wharton's jelly)allogeneicepilepsianeurology2016experimental therapyPoland14
1288cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland55
1289cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland62
1290cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2016experimental therapyPoland58
1291cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland12
1292cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland66
1293cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland55
1294cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland49
1295cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland55
1296cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland58
1297cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2016experimental therapyPoland4
1298cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2016experimental therapyPoland1
1299cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland3
1300cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland9
1301cord tissue (Wharton's jelly)allogeneicglobal developmental delayneurology2016experimental therapyPoland6
1302cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland66
1303cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland39
1304cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland13
1305cord tissue (Wharton's jelly)allogeneicdevelopmental delayneurology2016experimental therapyPoland7
1306cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2016experimental therapyPoland7
1307cord tissue (Wharton's jelly)allogeneicoptic neuropathyophthalmology2016experimental therapyPoland66
1308cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2016experimental therapyPoland38
1309cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland8
1310cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland3
1311cord tissue (Wharton's jelly)allogeneicoptic neuropathyophthalmology2016experimental therapyPoland79
1312cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2016experimental therapyPoland54
1313cord tissue (Wharton's jelly)allogeneicdystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland14
1314cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland47
1315cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland49
1316cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland61
1317cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2016experimental therapyPoland23
1318cord tissue (Wharton's jelly)allogeneicage-related macular degenerationophthalmology2016experimental therapyPoland86
1319cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2016experimental therapyPoland54
1320cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2016experimental therapyPoland68
1321cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland13
1322cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland2
1323cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland5
1324cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland12
1325cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland12
1326cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2016experimental therapyPoland1
1327cord tissue (Wharton's jelly)allogeneicdevelopmental delayneurology2016experimental therapyPoland2
1328cord tissue (Wharton's jelly)allogeneicspinal muscular atrophyneurology2016experimental therapyPoland3
1329cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland59
1330cord tissue (Wharton's jelly)allogeneicspinal muscular atrophyneurology2016experimental therapyPoland34
1331cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland30
1332cord tissue (Wharton's jelly)allogeneicspinal muscular atrophyneurology2016experimental therapyPoland17
1333cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2016experimental therapyPoland37
1334cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland31
1335cord tissue (Wharton's jelly)allogeneicataxia hereditarianeurology2016experimental therapyPoland69
1336cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2016experimental therapyPoland31
1337cord tissue (Wharton's jelly)allogeneicno dataophthalmology2016experimental therapyPoland66
1338cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland53
1339cord tissue (Wharton's jelly)allogeneicpatella cartilage damageorthopedic2016experimental therapyPoland60
1340cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland10
1341cord tissue (Wharton's jelly)allogeneicencephalopathyneurology2016experimental therapyPoland3
1342cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2016experimental therapyPoland2
1343cord tissue (Wharton's jelly)allogeneicencephalopathyneurology2016experimental therapyPoland4
1344cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2016experimental therapyPolandno data
1345cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2016experimental therapyPoland59
1346cord tissue (Wharton's jelly)allogeneicatrophy of the optic nerveophthalmology2016experimental therapyPoland20
1347cord tissue (Wharton's jelly)allogeneicpatella cartilage damageorthopedic2016experimental therapyPoland53
1348cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland24
1349cord tissue (Wharton's jelly)allogeneicdystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland34
1350cord tissue (Wharton's jelly)allogeneiclimb-girdle muscular dystrophyneurology2016experimental therapyPoland32
1351cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland65
1352cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland52
1353cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland71
1354cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2016experimental therapyPoland60
1355cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland1
1356cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland7
1357cord tissue (Wharton's jelly)allogeneicspinal muscular atrophyneurology2016experimental therapyPoland1
1358cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2016experimental therapyPoland29
1359cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland68
1360cord tissue (Wharton's jelly)allogeneicchronic graft versus host diseasehematology2016experimental therapyPoland0
1361cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland44
1362cord tissue (Wharton's jelly)allogeneicdystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland9
1363cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2016experimental therapyPoland24
1364cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland66
1365cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2016experimental therapyPoland15
1366cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland6
1367cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland10
1368cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland16
1369cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland6
1370cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2016experimental therapyPoland41
1371cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland51
1372cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland49
1373cord tissue (Wharton's jelly)allogeneicautismneurology2016experimental therapyPoland20
1374cord tissue (Wharton's jelly)allogeneicfetal alcohol spectrum disorderneurology2016experimental therapyPoland5
1375cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland13
1376cord tissue (Wharton's jelly)allogeneictetraparesis spasticaorthopedic2016experimental therapyPoland58
1377cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland68
1378cord tissue (Wharton's jelly)allogeneicchondronecrosis femoral condyleorthopedic2016experimental therapyPoland54
1379cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland55
1380cord tissue (Wharton's jelly)allogeneic - family + allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland41
1381cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland72
1382cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland56
1383cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2016experimental therapyPoland2
1384cord tissue (Wharton's jelly)allogeneictetraparesis spasticaorthopedic2016experimental therapyPoland18
1385cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland4
1386cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland48
1387cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland56
1388cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland66
1389cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPolandno data
1390cord tissue (Wharton's jelly)allogeneicgangliosidosis t. 1neurology2016experimental therapyPoland1
1391cord tissue (Wharton's jelly)allogeneicepilepsianeurology2016experimental therapyPoland14
1392cord tissue (Wharton's jelly)allogeneicepileptic encephalopathyneurology2016experimental therapyPoland3
1393cord tissue (Wharton's jelly)allogeneicpolineuropathyneurology2016experimental therapyPoland70
1394cord tissue (Wharton's jelly)allogeneicdiffuse cartilage damage left medial compartment of the kneeorthopedic2016experimental therapyPoland50
1395cord tissue (Wharton's jelly)allogeneicStargardt's diseaseophthalmology2016experimental therapyPoland37
1396cord tissue (Wharton's jelly)allogeneicmyopia, hyperopia, astigmatism, abnormal refraction and accommodation, optic atrophyophthalmology2016experimental therapyPoland37
1397cord tissue (Wharton's jelly)allogeneicoptic neuropathyophthalmology2016experimental therapyPoland33
1398cord tissue (Wharton's jelly)allogeneicepilepsianeurology2016experimental therapyPoland16
1399cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland3
1400cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2016experimental therapyPoland17
1401cord tissue (Wharton's jelly)allogeneicinjuries to the spinal nerveneurology2016experimental therapyPoland0
1402cord tissue (Wharton's jelly)allogeneiccartilage damageorthopedic2016experimental therapyPoland57
1403cord tissue (Wharton's jelly)allogeneicdystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland4
1404cord tissue (Wharton's jelly)allogeneiclimb-girdle muscular dystrophyneurology2016experimental therapyPoland44
1405cord tissue (Wharton's jelly)allogeneicdystrophia progressiva pseudohypertrophica /DMDneurology2016experimental therapyPoland10
1406cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2016experimental therapyPoland4
1407cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2016experimental therapyPoland4
1408cord tissue (Wharton's jelly)allogeneiccerebellar syndromeneurology2016experimental therapyPoland28
1409cord tissue (Wharton's jelly)allogeneicneurodevelopmental disorderneurology2016experimental therapyPoland4
1410cord tissue (Wharton's jelly)allogeneictetraparesisorthopedic2016experimental therapyPoland27
1411cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland61
1412cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2016experimental therapyPoland44
1413cord tissue (Wharton's jelly)allogeneicdegeneration of the cartilage of the knee jointorthopedic2016experimental therapyPoland54
1414cord tissue (Wharton's jelly)allogeneicdystrophia progressiva pseudohypertrophica /BMDneurology2016experimental therapyPoland19
1415cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland15
1416cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland31
1417cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2016experimental therapyPoland33
1418cord tissue (Wharton's jelly)allogeneicendometrial atrophyginecology2016experimental therapyPoland37
1419cord tissue (Wharton's jelly)allogeneicendometrial atrophyginecology2016experimental therapyPoland39
1420cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2016experimental therapyPoland38
1421cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2016experimental therapyPoland44
1422cord tissue (Wharton's jelly)allogeneicmeniscus damageorthopedic2016experimental therapyPoland35
1423cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland60
1424cord tissue (Wharton's jelly)allogeneicpremature ovarian failureginecology2016experimental therapyPoland23
1425cord tissue (Wharton's jelly)allogeneicpremature ovarian failureginecology2016experimental therapyPoland34
1426cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2016experimental therapyPoland55
1427cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2015experimental therapyPoland1
1428cord tissue (Wharton's jelly)allogeneicautismneurology2015experimental therapyPoland5
1429cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2015experimental therapyPoland23
1430cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland61
1431cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland61
1432cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland56
1433cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland51
1434cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland65
1435cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland60
1436cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland52
1437cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2015experimental therapyPoland3
1438cord tissue (Wharton's jelly)allogeneicdecerebration rigidityneurology2015experimental therapyPoland9
1439cord tissue (Wharton's jelly)allogeneicbilateral blindnessophthalmology2015experimental therapyPoland36
1440cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2015experimental therapyPoland0
1441cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2015experimental therapyPoland15
1442cord tissue (Wharton's jelly)allogeneicceroid lipofuscinosineurology2015experimental therapyPoland5
1443cord tissue (Wharton's jelly)allogeneicencephalopathyneurology2015experimental therapyPoland14
1444cord tissue (Wharton's jelly)allogeneicceroid lipofuscinosineurology2015experimental therapyPoland7
1445cord tissue (Wharton's jelly)allogeneicautismneurology2015experimental therapyPoland3
1446cord tissue (Wharton's jelly)allogeneic - family + allogeneiccerebral palsyneurology2015experimental therapyPoland7
1447cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2015experimental therapyPoland13
1448cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland59
1449cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2015experimental therapyPoland31
1450cord tissue (Wharton's jelly)allogeneicautismneurology2015experimental therapyPoland12
1451cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2015experimental therapyPoland8
1452cord tissue (Wharton's jelly)allogeneicdelayed psychomotor development, deafneneurology2015experimental therapyPoland3
1453cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland61
1454cord tissue (Wharton's jelly)allogeneictraumatic encephalopathyneurology2015experimental therapyPoland20
1455cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2015experimental therapyPoland18
1456cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2015experimental therapyPoland2
1457cord tissue (Wharton's jelly)allogeneicadrenoleukodystrophy, encephalopathyneurology2015experimental therapyPoland23
1458cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2015experimental therapyPoland40
1459cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2015experimental therapyPoland26
1460cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2015experimental therapyPoland37
1461cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland58
1462cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2015experimental therapyPoland35
1463cord tissue (Wharton's jelly)allogeneicspinal muscular atrophyneurology2015experimental therapyPoland0
1464cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2015experimental therapyPoland44
1465cord tissue (Wharton's jelly)allogeneicoptic neuropathyophthalmology2015experimental therapyPoland15
1466cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland61
1467cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2015experimental therapyPoland66
1468cord tissue (Wharton's jelly)allogeneiciatrogenic spinal cord injuryneurology2015experimental therapyPoland17
1469cord tissue (Wharton's jelly)allogeneicoptic neuropathyophthalmology2015experimental therapyPoland45
1470cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland62
1471cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2015experimental therapyPoland51
1472cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2015experimental therapyPoland12
1473cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland26
1474cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland27
1475cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2015experimental therapyPoland4
1476cord tissue (Wharton's jelly)allogeneicautismneurology2015experimental therapyPoland6
1477cord tissue (Wharton's jelly)allogeneicautismneurology2015experimental therapyPoland4
1478cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland63
1479cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2015experimental therapyPoland32
1480cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2015experimental therapyPoland22
1481cord tissue (Wharton's jelly)allogeneicsclerosis multiplexneurology2015experimental therapyPoland33
1482cord tissue (Wharton's jelly)allogeneicdelayed psychomotor developmentneurology2015experimental therapyPoland3
1483cord tissue (Wharton's jelly)allogeneicspina bifidaneurology2015experimental therapyPoland2
1484cord tissue (Wharton's jelly)allogeneiccerebellar ataxianeurology2015experimental therapyPoland18
1485cord tissue (Wharton's jelly)allogeneicspinocerebellar ataxianeurology2015experimental therapyPoland24
1486cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland67
1487cord tissue (Wharton's jelly)allogeneicautismneurology2015experimental therapyPoland5
1488cord tissue (Wharton's jelly)allogeneicpolineuropathyneurology2015experimental therapyPoland74
1489cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland37
1490cord tissue (Wharton's jelly)allogeneicstrokeneurology2015experimental therapyPoland62
1491cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland58
1492cord tissue (Wharton's jelly)allogeneicfacio-scapulo-humeral muscular dystrophyneurology2015experimental therapyPoland30
1493cord tissue (Wharton's jelly)allogeneicchronic graft versus host diseasehematology2015experimental therapyPoland10
1494cord tissue (Wharton's jelly)allogeneicsevere developmental delayneurology2015experimental therapyPoland1
1495cord tissue (Wharton's jelly)allogeneicspinal muscular atrophyneurology2015experimental therapyPoland26
1496cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland46
1497cord tissue (Wharton's jelly)allogeneicautismneurology2015experimental therapyPoland8
1498cord tissue (Wharton's jelly)allogeneicencephalopathyneurology2015experimental therapyPoland0
1499cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2015experimental therapyPoland6
1500cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland48
1501cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2015experimental therapyPoland21
1502cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2015experimental therapyPoland9
1503cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2015experimental therapyPoland13
1504cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland61
1505cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2015experimental therapyPoland54
1506cord tissue (Wharton's jelly)allogeneicintracranial injuryneurology2015experimental therapyPoland24
1507cord tissue (Wharton's jelly)allogeneicstrokeneurology2015experimental therapyPoland54
1508cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2015experimental therapyPoland24
1509cord tissue (Wharton's jelly)allogeneicgonarthrosiorthopedic2015experimental therapyPoland65
1510cord tissue (Wharton's jelly)allogeneicleukodystrophyneurology2015experimental therapyPoland18
1511cord tissue (Wharton's jelly)allogeneicspinal cord injuryorthopedic2015experimental therapyPoland34
1512cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2015experimental therapyPoland1
1513cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2015experimental therapyPoland14
1514cord tissue (Wharton's jelly)allogeneicanterior ischemic optic neuropathyophthalmology2015experimental therapyPoland54
1515cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2015experimental therapyPoland16
1516cord tissue (Wharton's jelly)allogeneicretinitis pigmentosaophthalmology2015experimental therapyPoland34
1517cord tissue (Wharton's jelly)allogeneiccerebellar ataxianeurology2015experimental therapyPoland26
1518cord tissue (Wharton's jelly)allogeneic - family + allogeneicencephalopathyneurology2015experimental therapyPoland11
1519cord tissue (Wharton's jelly)allogeneicneuropathyneurology2014experimental therapyPoland23
1520cord tissue (Wharton's jelly)allogeneicautismneurology2014experimental therapyPoland12
1521cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2014experimental therapyPoland6
1522cord tissue (Wharton's jelly)allogeneiccentral motor coordination impairment after hypoxic ischaemia lesion at birthneurology2014experimental therapyPoland2
1523cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2014experimental therapyPoland60
1524cord tissue (Wharton's jelly)allogeneicamyotrophic lateral sclerosineurology2014experimental therapyPoland24
1525cord tissue (Wharton's jelly)allogeneicautismneurology2014experimental therapyPoland8
1526cord tissue (Wharton's jelly)allogeneicmuscular dystrophyneurology2014experimental therapyPoland6
1527cord tissue (Wharton's jelly)allogeneicbirth asphyxia, retinopathyneurology2014experimental therapyPoland0
1528cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2014experimental therapyPoland4
1529cord tissue (Wharton's jelly)allogeneiccerebral palsyneurology2014experimental therapyPoland15
1530cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2013experimental therapyPoland18
1531cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2013experimental therapyPoland2
1532cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2013experimental therapyPoland3
1533cord tissue (Wharton's jelly)allogeneicacute myeloid leukemiahematology2013experimental therapyPoland3
1534cord tissue (Wharton's jelly)allogeneicchronic graft versus host diseasehematology2013experimental therapyPoland18
1535cord tissue (Wharton's jelly)allogeneicchronic graft versus host diseasehematology2013experimental therapyPoland17
1536cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2012experimental therapyPoland19
1537cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2012experimental therapyPoland7
1538cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2012experimental therapyPoland4
1539cord tissue (Wharton's jelly)allogeneicacute graft versus host diseasehematology2011experimental therapyPoland17
1540adipose tissueautologougonarthrosiorthopedic2020experimental therapyPoland52.8
1541adipose tissueautologouother acquired deformities of the ankle and footorthopedic2020experimental therapyPoland41.6
1542adipose tissueautologouinternal damage to the knee jointorthopedic2020experimental therapyPoland53.6
1543adipose tissueautologougonarthrosiorthopedic2020experimental therapyPoland63.4
1544adipose tissueautologougonarthrosi, shoulder osteoarthritisorthopedic2020experimental therapyPoland42.5
1545adipose tissueautologougonarthrosiorthopedic2020experimental therapyPoland41.1
1546adipose tissueautologougonarthrosiorthopedic2020experimental therapyPoland34.8
1547adipose tissueautologouinternal damage to the knee jointorthopedic2020experimental therapyPoland49.2
1548adipose tissueautologouomarthrosiorthopedic2020experimental therapyPoland70.1
1549adipose tissueautologougonarthrosiorthopedic2020experimental therapyPoland48.1
1550adipose tissueautologouscardermatology2019clinical trialPolandno data
1551adipose tissueautologouscardermatology2019clinical trialPolandno data
1552adipose tissueautologoucoxarthrosiorthopedic2019applicationPoland34
1553adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1554adipose tissueautologouscardermatology2019clinical trialPolandno data
1555adipose tissueautologouscardermatology2019clinical trialPolandno data
1556adipose tissueautologouscardermatology2019clinical trialPolandno data
1557adipose tissueautologouscardermatology2019clinical trialPolandno data
1558adipose tissueautologouscardermatology2019clinical trialPolandno data
1559adipose tissueautologouscardermatology2019clinical trialPolandno data
1560adipose tissueautologouscardermatology2019clinical trialPolandno data
1561adipose tissueautologouscardermatology2019clinical trialPolandno data
1562adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1563adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1564adipose tissueautologouscardermatology2019clinical trialPolandno data
1565adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1566adipose tissueautologouscardermatology2019clinical trialPolandno data
1567adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1568adipose tissueautologouscardermatology2019clinical trialPolandno data
1569adipose tissueautologouscardermatology2019clinical trialPolandno data
1570adipose tissueautologouscardermatology2019clinical trialPolandno data
1571adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1572adipose tissueautologouscardermatology2019clinical trialPolandno data
1573adipose tissueautologouscardermatology2019clinical trialPolandno data
1574adipose tissueautologouscardermatology2019clinical trialPolandno data
1575adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1576adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1577adipose tissueautologouscardermatology2019clinical trialPolandno data
1578adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1579adipose tissueautologouscardermatology2019clinical trialPolandno data
1580adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1581adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1582adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1583adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1584adipose tissueautologouscardermatology2019clinical trialPolandno data
1585adipose tissueautologouscardermatology2019clinical trialPolandno data
1586adipose tissueautologouscardermatology2019clinical trialPolandno data
1587adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1588adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1589adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1590adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1591adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1592adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1593adipose tissueautologoucutis laxadermatology2019clinical trialPolandno data
1594adipose tissueautologougonarthrosiorthopedic2019experimental therapyPoland44.11
1595adipose tissueautologouosteoarthritiorthopedic2019experimental therapyPoland52.8
1596adipose tissueautologouosteoarthritiorthopedic2019experimental therapyPoland44.8
1597adipose tissueautologouosteoarthritiorthopedic2019experimental therapyPoland52.5
1598adipose tissueautologouosteoarthritiorthopedic2019experimental therapyPoland54.5
1599adipose tissueautologouosteoarthritiorthopedic2019experimental therapyPoland55.11
1600adipose tissueautologousoft tissue diseases related to use, overload and pressureorthopedic2019experimental therapyPoland45.3
1601adipose tissueautologougonarthrosiorthopedic2019experimental therapyPoland65.3
1602adipose tissueautologougonarthrosiorthopedic2019experimental therapyPoland68.6
1603adipose tissueautologouchondromalaciaorthopedic2019experimental therapyPoland48.8
1604adipose tissueautologoumild arthritiorthopedic2019experimental therapyPoland21.2
1605adipose tissueautologoumild arthritiorthopedic2019experimental therapyPoland68.5
1606adipose tissueautologougonarthrosiorthopedic2019experimental therapyPoland36.1
1607adipose tissueautologougonarthrosiorthopedic2019experimental therapyPoland54.3
1608adipose tissueautologoushoulder osteoarthritiorthopedic2019experimental therapyPoland47.1
1609adipose tissueautologouchondromalaciaorthopedic2019experimental therapyPoland38.6
1610adipose tissueautologoucoxarthrosiorthopedic2018applicationPoland53
1611adipose tissueautologougonarthrosiorthopedic2018applicationPoland69
1612adipose tissueautologougonarthrosiorthopedic2018applicationPoland42
1613adipose tissueautologoucondition after injury of the left knee jointorthopedic2018applicationPoland33
1614adipose tissueautologouscardermatology2018clinical trialPolandno data
1615adipose tissueautologouscardermatology2018clinical trialPolandno data
1616adipose tissueautologoucutis laxadermatology2018clinical trialPolandno data
1617adipose tissueautologoucutis laxadermatology2018clinical trialPolandno data
1618adipose tissueautologouscardermatology2018clinical trialPolandno data
1619adipose tissueautologouscardermatology2018clinical trialPolandno data
1620adipose tissueautologouscardermatology2018clinical trialPolandno data
1621adipose tissueautologoucutis laxadermatology2018clinical trialPolandno data
1622adipose tissueautologoucutis laxadermatology2018clinical trialPolandno data
1623adipose tissueautologoucutis laxadermatology2018clinical trialPolandno data
1624adipose tissueautologouscardermatology2018clinical trialPolandno data
1625adipose tissueautologoucutis laxadermatology2018clinical trialPolandno data
1626adipose tissueautologouscardermatology2018clinical trialPolandno data
1627adipose tissueautologouscardermatology2018clinical trialPolandno data
1628adipose tissueautologouscardermatology2018clinical trialPolandno data
1629adipose tissueautologouscardermatology2018clinical trialPolandno data
1630adipose tissueautologoucutis laxadermatology2018clinical trialPolandno data
1631adipose tissueautologoucutis laxadermatology2018clinical trialPolandno data
1632adipose tissueautologouscardermatology2018clinical trialPolandno data
1633bone marrowallogeneicT-cell acute lymphoblastic leukemiahematology2020standard therapyPoland12
1634bone marrowallogeneicsevere aplastic anaemiahematology2020standard therapyAustralia5
1635bone marrowallogeneicchronic granulomatous diseasehematology2020standard therapyTurkey6
1636bone marrowallogeneicacute myelogenous leukemiahematology2020standard therapyBrazil16
1637bone marrowallogeneicmyelodysplastic syndromehematology2020standard therapyBelgium52
1638bone marrowallogeneicsecondary acute myelogenous leukemiahematology2020standard therapyGermany63
1639bone marrowallogeneicβ - thalassemia majorhematology2020standard therapyGermany13
1640bone marrowallogeneicosteopetrosihematology2020standard therapySpain1
1641bone marrowallogeneicacute lymphoblastic leukemiahematology2020standard therapyFrance14
1642bone marrowallogeneicimmune deficiency, neutropeniahematology2020standard therapyUSA4
1643bone marrowallogeneicsevere aplastic anaemiahematology2020standard therapyUSA57
1644bone marrowallogeneicacute lymphoblastic leukemiahematology2020standard therapyAustria1
1645bone marrowallogeneicacute lymphoblastic leukemiahematology2020standard therapyUSA52
1646bone marrowallogeneicacute lymphoblastic leukemiahematology2020standard therapySwitzerland66
1647bone marrowallogeneicsevere aplastic anaemiahematology2020standard therapyUSA27
1648bone marrowallogeneicmyelodysplastic syndromehematology2020standard therapyUSA54
1649bone marrowallogeneicsecondary acute myelogenous leukemiahematology2020standard therapyGermany68
1650bone marrowallogeneicaplastic anaemiahematology2019standard therapyCanada18
1651bone marrowallogeneicno datahematology2019standard therapyITALY59
1652bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyUSA52
1653bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyPoland5
1654bone marrowallogeneicaplastic anaemiahematology2019standard therapyRomania8
1655bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyUSA66
1656bone marrowallogeneicno datahematology2019standard therapyUnited Kingdom3
1657bone marrowallogeneicFanconi anaemiahematology2019standard therapyTurkey6
1658bone marrowallogeneicsevere aplastic anaemiahematology2019standard therapyGermany11
1659bone marrowallogeneicthalassemia majorhematology2019standard therapySweden13
1660bone marrowallogeneicmyelodysplastic syndromehematology2019standard therapyUSA75
1661bone marrowallogeneicmyelodysplastic syndromehematology2019standard therapyUSA57
1662bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyCanada14
1663bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyFrance21
1664bone marrowallogeneiccongenital amegakaryocytic thrombocytopeniahematology2019standard therapyUnited Kingdom1
1665bone marrowallogeneicaplastic anaemiahematology2019standard therapySpain10
1666bone marrowallogeneicosteopetrosimetabolic2019standard therapyIsrael1
1667bone marrowallogeneicchronic myeloid leukemiahematology2019standard therapyPoland9
1668bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyUSA17
1669bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapySpain42
1670bone marrowallogeneicno datahematology2019standard therapyPoland1
1671bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyAustralia65
1672bone marrowallogeneicsevere aplastic anaemiahematology2019standard therapyUSA12
1673bone marrowallogeneicDiamond-Balckfan anaemiahematology2019standard therapyPoland2
1674bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapySlovakia10
1675bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyPoland4
1676bone marrowallogeneicNijmegen breakage syndromehematology2019standard therapyPoland6
1677bone marrowallogeneicchronic granulomatous diseasehematology2019standard therapyFrance7
1678bone marrowallogeneicHurler syndromehematology2019standard therapyUSA2
1679bone marrowallogeneicsevere aplastic anaemiahematology2019standard therapyItaly5
1680bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyNorway15
1681bone marrowallogeneicmyeloproliferative syndromehematology2019standard therapyTurkey2
1682bone marrowallogeneicthalassemia majorhematology2019standard therapyTurkey5
1683bone marrowallogeneicsevere aplastic anaemiahematology2019standard therapyIndia17
1684bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyNorway47
1685bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyUSA49
1686bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyUSA5
1687bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyGermany67
1688bone marrowallogeneicmyelodysplastic syndromehematology2019standard therapyUSA63
1689bone marrowallogeneicC-HHYP cartilage-hair hypoplasiahematology2019standard therapyUSA2
1690bone marrowallogeneicmyelodysplastic syndromehematology2019standard therapyGermany8
1691bone marrowallogeneicOHIS - other histiocytic disorderhematology2019standard therapyUSA5
1692bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyItaly47
1693bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyUSA59
1694bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyUSA64
1695bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyPoland2
1696bone marrowallogeneicHodgkin’s lymphomahematology2019standard therapyUSA62
1697bone marrowallogeneicSchwachmann Diamond Anemiahematology2019standard therapySlovakia20
1698bone marrowallogeneicvery severe aplastic anaemiahematology2019standard therapyGermany13
1699bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyGermany57
1700bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyTurkey12
1701bone marrowallogeneicnon-Hodgkin lymphomahematology2019standard therapyUSA43
1702bone marrowallogeneicmucopolysaccharidosis type Imetabolic2019standard therapyPoland2
1703bone marrowallogeneicadrenoleukodystrophymetabolic2019standard therapyUSA3
1704bone marrowallogeneicno datahematology2019standard therapyPoland64
1705bone marrowallogeneicsevere aplastic anaemiahematology2019standard therapyPoland4
1706bone marrowallogeneicosteopetrosimetabolic2019standard therapyPoland0.5
1707bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyUSA20
1708bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyItaly17
1709bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyUnited Kingdom11
1710bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyUSA48
1711bone marrowallogeneicmyelodysplastic syndromehematology2019standard therapyTurkey14
1712bone marrowallogeneicparoxysmal nocturnal hemoglobinuriahematology2019standard therapyTurkey14
1713bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyUSA30
1714bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyFrance3
1715bone marrowallogeneicnon-Hodgkin lymphomahematology2019standard therapyUSA55
1716bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyUSA51
1717bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyTurkey32
1718bone marrowallogeneicNijmegen breakage syndromehematology2019standard therapyGermany16
1719bone marrowallogeneicthalassemia majorhematology2019standard therapyItaly10
1720bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyBrazil8
1721bone marrowallogeneicchronic myeloid leukemiahematology2019standard therapyPoland35
1722bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyUSA20
1723bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyFrance14
1724bone marrowallogeneicsevere aplastic anaemiahematology2019standard therapyUSA22
1725bone marrowallogeneicmyelodysplastic syndromehematology2019standard therapyUSA75
1726bone marrowallogeneicmyelodysplastic syndromehematology2019standard therapyUSA62
1727bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyGermany3
1728bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyCanada10
1729bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyNorway13
1730bone marrowallogeneicmyelodysplastic syndromehematology2019standard therapyGermany27
1731bone marrowallogeneicHurler syndromehematology2019standard therapyRussia3
1732bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyCanada15
1733bone marrowallogeneicsevere aplastic anaemiahematology2019standard therapyBelgium11
1734bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyUSA47
1735bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyPoland1
1736bone marrowallogeneicmyelodysplastic syndromehematology2019standard therapyUSA67
1737bone marrowallogeneicsevere aplastic anaemiahematology2019standard therapyItaly14
1738bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyBelaru3
1739bone marrowallogeneicimmune deficiencyhematology2019standard therapyUSA1
1740bone marrowallogeneicprimary immunodeficiencyhematology2019standard therapyBelaru2
1741bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyTurkey5
1742bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyGreece16
1743bone marrowallogeneicaplastic anaemiahematology2019standard therapyUSA25
1744bone marrowallogeneicsevere aplastic anaemiahematology2019standard therapyUSA3
1745bone marrowallogeneicprimary immunodeficiencyhematology2019standard therapySpain22
1746bone marrowallogeneicaplastic anaemiahematology2019standard therapySlovenia30
1747bone marrowallogeneicacute lymphoblastic leukemiahematology2019standard therapyUSA3
1748bone marrowallogeneicacute myelogenous leukemiahematology2019standard therapyNorway42
1749bone marrowallogeneicmyelodysplastic syndromehematology2018standard therapyItaly4
1750bone marrowallogeneicchronic granulomatous diseasehematology2018standard therapySwitzerland3
1751bone marrowallogeneicjuvenile myelomonocytic leukemiahematology2018standard therapyHungary11
1752bone marrowallogeneicHodgkin’s lymphomahematology2018standard therapyUSA31
1753bone marrowallogeneicbilineal leukemia -acute lymphoblastic leukemia, acute myelogenous leukemiahematology2018standard therapyBelaru2
1754bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyItaly9/12
1755bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapySwitzerland67
1756bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyBrazil3
1757bone marrowallogeneicno datahematology2018standard therapySpain48
1758bone marrowallogeneicno datahematology2018standard therapyGermany16
1759bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyPoland12
1760bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyItaly36
1761bone marrowallogeneicthalassemia majorhematology2018standard therapySweden14
1762bone marrowallogeneicsevere aplastic anaemiahematology2018standard therapyUSA19
1763bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA50
1764bone marrowallogeneicdiffuse large B-cell lymphomahematology2018standard therapyGermany68
1765bone marrowallogeneicsevere combined immunodeficiencyhematology2018standard therapyIsrael2
1766bone marrowallogeneicsevere aplastic anaemiahematology2018standard therapyItaly14
1767bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA11
1768bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyArgentina14
1769bone marrowallogeneicchronic granulomatous diseasehematology2018standard therapyUSA2
1770bone marrowallogeneicsevere combined immunodeficiencyhematology2018standard therapyUSA1
1771bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA20
1772bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyCanada8
1773bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA1
1774bone marrowallogeneicFanconi anaemiahematology2018standard therapyUSA3
1775bone marrowallogeneicmyelodysplastic syndromehematology2018standard therapyGermany12
1776bone marrowallogeneicHurler syndromehematology2018standard therapyUSA2
1777bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA8
1778bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyItaly71
1779bone marrowallogeneicmyelodysplastic syndromehematology2018standard therapyFrance2
1780bone marrowallogeneicmyelodysplastic syndromehematology2018standard therapyUSA70
1781bone marrowallogeneicaplastic anaemiahematology2018standard therapyPoland24
1782bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA49
1783bone marrowallogeneicsevere aplastic anaemiahematology2018standard therapyIndia27
1784bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyPoland3
1785bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyItaly66
1786bone marrowallogeneicthalassemia majorhematology2018standard therapyTurkey12
1787bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyBelgium41
1788bone marrowallogeneicT-cell leukemia/lymphomahematology2018standard therapyArgentina10
1789bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyPoland7
1790bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyAustria8
1791bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA32
1792bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA17
1793bone marrowallogeneicchronic granulomatous diseasehematology2018standard therapyUSA2
1794bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyCanada25
1795bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA66
1796bone marrowallogeneicnon-Hodgkin lymphomahematology2018standard therapyUSA62
1797bone marrowallogeneicmyelodysplastic syndromehematology2018standard therapyItaly4
1798bone marrowallogeneicmyelodysplastic syndromehematology2018standard therapyHungary4
1799bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyItaly70
1800bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyItaly14
1801bone marrowallogeneicsevere combined immunodeficiencyhematology2018standard therapyPoland7/12
1802bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyPoland8
1803bone marrowallogeneicsevere aplastic anaemiahematology2018standard therapyPoland18
1804bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyUnited Kingdom6
1805bone marrowallogeneicother non-malignant diseasehematology2018standard therapyUSA29
1806bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyAustralia59
1807bone marrowallogeneicsevere aplastic anaemiahematology2018standard therapyUSA2
1808bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA12
1809bone marrowallogeneicno datahematology2018standard therapyGermany52
1810bone marrowallogeneicmyelodysplastic syndromehematology2018standard therapyUSA31
1811bone marrowallogeneicchronic granulomatous diseasehematology2018standard therapyGermany1
1812bone marrowallogeneicno datahematology2018standard therapyUSA1
1813bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA72
1814bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA40
1815bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyGermany6
1816bone marrowallogeneicFanconi anaemiahematology2018standard therapyBrazil3
1817bone marrowallogeneicsevere aplastic anaemiahematology2018standard therapyGermany20
1818bone marrowallogeneiccongenital hypoplastic anemiahematology2018standard therapyCanada2
1819bone marrowallogeneicsevere aplastic anaemiahematology2018standard therapyIran6
1820bone marrowallogeneicacute lymphoblastic leukemiahematology2018standard therapyCanada18
1821bone marrowallogeneicmyelodysplastic syndromehematology2018standard therapyCanada37
1822bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA22
1823bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyUSA60
1824bone marrowallogeneicno datahematology2018standard therapyBrazil1
1825bone marrowallogeneicsevere combined immunodeficiencyhematology2018standard therapyTurkey21
1826bone marrowallogeneicacute myelogenous leukemiahematology2018standard therapyCanada53
1827bone marrowallogeneicacute lymphoblastic leukemia relapsehematology2018standard therapyGermany14
1828bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyPoland6
1829bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyGermany76
1830bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyTurkey22
1831bone marrowallogeneicchronic granulomatous diseasehematology2017standard therapyPoland2
1832bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyGermany65
1833bone marrowallogeneicmyelodysplastic syndromehematology2017standard therapyItaly60
1834bone marrowallogeneicmyelodysplastic syndromehematology2017standard therapyUSA61
1835bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyRussia30
1836bone marrowallogeneicchronic granulomatous diseasehematology2017standard therapyPoland4
1837bone marrowallogeneicleukemiahematology2017standard therapyUSA40
1838bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyUnited Kingdom10
1839bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyHungary14
1840bone marrowallogeneicsevere combined immunodeficiencyhematology2017standard therapyTurkey6
1841bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyItaly55
1842bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyUSA67
1843bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyPoland16
1844bone marrowallogeneicsevere combined immunodeficiencyhematology2017standard therapyLithuania1
1845bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyItaly13
1846bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyItaly38
1847bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyUnited Kingdom9
1848bone marrowallogeneicsevere combined immunodeficiencyhematology2017standard therapyCanada1
1849bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyRussia59
1850bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyUSA21
1851bone marrowallogeneicsevere combined immunodeficiencyhematology2017standard therapyTurkey2
1852bone marrowallogeneichyper IgM syndromehematology2017standard therapyFinland2
1853bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyAustria3
1854bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyRussia1
1855bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyItaly59
1856bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyUSA57
1857bone marrowallogeneicpure red cell aplasiahematology2017standard therapyUSA5
1858bone marrowallogeneicthalassemia majorhematology2017standard therapyTurkey11
1859bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyItaly10
1860bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyCzech Republic68
1861bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyUSA60
1862bone marrowallogeneicFanconi anaemiahematology2017standard therapyRussia10
1863bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyUSA10
1864bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyUSA17
1865bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyUSA51
1866bone marrowallogeneicjuvenile myelomonocytic leukemiahematology2017standard therapyFinland1
1867bone marrowallogeneicacute megakaryocytic leukemiahematology2017standard therapySpain2
1868bone marrowallogeneicchronic myeloid leukemiahematology2017standard therapyUSA51
1869bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyItaly56
1870bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyRussia54
1871bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyFrance24
1872bone marrowallogeneicsevere combined immunodeficiencyhematology2017standard therapyPoland1
1873bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyUnited Kingdom8
1874bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyItaly9
1875bone marrowallogeneicno datahematology2017standard therapyFrance32
1876bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyBrazil14
1877bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyItaly4
1878bone marrowallogeneicWiskott-Aldrich syndromehematology2017standard therapyIran2
1879bone marrowallogeneicT-cell leukemia/lymphomahematology2017standard therapyIran18
1880bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyItaly7
1881bone marrowallogeneicmyeloma multiplexhematology2017standard therapyCanada50
1882bone marrowallogeneicother combined immunodeficiencyhematology2017standard therapyUSA11
1883bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyItaly2
1884bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyFrance12
1885bone marrowallogeneicmyelodysplastic syndromehematology2017standard therapyNorway2
1886bone marrowallogeneicNijmegen breakage syndromehematology2017standard therapyPoland8
1887bone marrowallogeneicsecondary acute myelogenous leukemia after Ewing sarcomahematology2017standard therapyGermany16
1888bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyIndia7
1889bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyUSA18
1890bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyFrance2
1891bone marrowallogeneicsevere combined immunodeficiencyhematology2017standard therapyTurkey8
1892bone marrowallogeneicFanconi anaemiahematology2017standard therapyBelaru10
1893bone marrowallogeneicacute lymphoblastic leukemiahematology2017standard therapyHungary7
1894bone marrowallogeneicacute myelogenous leukemiahematology2017standard therapyUSA19
1895bone marrowallogeneicprimary immunodeficiency, Nijmegen breakage syndromehematology2017standard therapyBelaru6
1896bone marrowallogeneicosteopetrosimetabolic2016standard therapyRussia6
1897bone marrowallogeneicsevere combined immunodeficiencyhematology2016standard therapyRomania2
1898bone marrowallogeneicT-cell acute lymphoblastic leukemiahematology2016standard therapyItaly4
1899bone marrowallogeneicno datano data2016standard therapyItaly3
1900bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyItaly64
1901bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyItaly9
1902bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapySpain55
1903bone marrowallogeneicFanconi anaemiahematology2016standard therapyEstonia7
1904bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyItaly6
1905bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyItaly64
1906bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyItaly14
1907bone marrowallogeneicbiphenotypic leukemiahematology2016standard therapyBrazil27
1908bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyGermany7
1909bone marrowallogeneicosteopetrosimetabolic2016standard therapyGermany1
1910bone marrowallogeneicsevere aplastic anaemiahematology2016standard therapyFrance9
1911bone marrowallogeneicno datano data2016standard therapyPoland7
1912bone marrowallogeneicHurler syndromemetabolic2016standard therapyUnited Kingdom2
1913bone marrowallogeneicsevere combined immunodeficiencyhematology2016standard therapyTurkey4
1914bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyCanada11
1915bone marrowallogeneicmyelofibrosihematology2016standard therapyGermany31
1916bone marrowallogeneicDiGeorge syndromehematology2016standard therapyNetherland24
1917bone marrowallogeneicHodgkin’s lymphomahematology2016standard therapyItaly17
1918bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyBelaru12
1919bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyBelaru18
1920bone marrowallogeneicsevere combined immunodeficiencyhematology2016standard therapyPoland7/12
1921bone marrowallogeneicsevere aplastic anaemiahematology2016standard therapyFrance9
1922bone marrowallogeneicsevere aplastic anaemia / paroxymal nocturnal haemoglobinuriahematology2016standard therapyPoland17
1923bone marrowallogeneicmyelodysplastic syndromehematology2016standard therapyHungary1
1924bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyItaly67
1925bone marrowallogeneicmyelodysplastic syndromehematology2016standard therapySpain56
1926bone marrowallogeneicFanconi anaemiahematology2016standard therapyNetherland41
1927bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyFrance5
1928bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyUnited Kingdom29
1929bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyBelaru25
1930bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyNew Zealand1
1931bone marrowallogeneicsevere combined immunodeficiencyhematology2016standard therapyGermany12
1932bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyPoland5
1933bone marrowallogeneicno datahematology2016standard therapyPoland33
1934bone marrowallogeneicnon-Hodgkin lymphomahematology2016standard therapyItaly46
1935bone marrowallogeneicaplastic anaemiahematology2016standard therapyAustria20
1936bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyCroatia33
1937bone marrowallogeneicmyeloproliferative syndromehematology2016standard therapyPoland22
1938bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyIreland39
1939bone marrowallogeneicDiamond-Balckfan anaemiahematology2016standard therapyGermany2
1940bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyCzech Republic9
1941bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyBelaru15
1942bone marrowallogeneicjuvenile myelomonocytic leukemiahematology2016standard therapyGermany3
1943bone marrowallogeneicacute myelogenous leukemiahematology2016standard therapyFinland45
1944bone marrowallogeneicanaemiahematology2016standard therapyGermany16
1945bone marrowallogeneicacute lymphoblastic leukemiahematology2016standard therapyGermany6
1946bone marrowallogeneicanaemiahematology2016standard therapyItaly5
1947bone marrowallogeneichigh-risk acute lymphoblastic leukemiahematology2016standard therapyPoland18
1948peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyUnited Kingdom64
1949peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyGermany64
1950peripheral bloodallogeneicnon-Hodgkin lymphomahematology2020standard therapyGermany65
1951peripheral bloodallogeneicsecondary acute myelogenous leukemiahematology2020standard therapyHungary43
1952peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyUSA72
1953peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyUSA63
1954peripheral bloodallogeneicmyelofibrosihematology2020standard therapyUnited Kingdom63
1955peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyGermany54
1956peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyUSA64
1957peripheral bloodallogeneicmyelodysplastic syndromehematology2020standard therapyUnited Kingdom71
1958peripheral bloodallogeneicacute lymphoblastic leukemiahematology2020standard therapyPoland54
1959peripheral bloodallogeneicsecondary acute myelogenous leukemiahematology2020standard therapyGermany67
1960peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyArgentina67
1961peripheral bloodallogeneicmyelodysplastic syndromehematology2020standard therapyUSA67
1962peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyUSA37
1963peripheral bloodallogeneicacute lymphoblastic leukemiahematology2020standard therapyUSA72
1964peripheral bloodallogeneicchronic myeloid leukemiahematology2020standard therapyGermany61
1965peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyPoland64
1966peripheral bloodallogeneicparoxysmal nocturnal hemoglobinuriahematology2020standard therapyPoland57
1967peripheral bloodallogeneicchronic lymphocytic leukemiahematology2020standard therapyGermany49
1968peripheral bloodallogeneicmyelodysplastic syndromehematology2020standard therapyFrance59
1969peripheral bloodallogeneicmantle cell lymphomahematology2020standard therapyLithuania56
1970peripheral bloodallogeneicmyelodysplastic syndromehematology2020standard therapyUSA60
1971peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyBelgium70
1972peripheral bloodallogeneicsevere combined immunodeficiencyhematology2020standard therapySweden2
1973peripheral bloodallogeneicacute lymphoblastic leukemiahematology2020standard therapyLithuania41
1974peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyUSA46
1975peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyUSA65
1976peripheral bloodallogeneicmyelodysplastic syndromehematology2020standard therapyUSA62
1977peripheral bloodallogeneicT-cell-prolymphocytic leukemiahematology2020standard therapyGermany55
1978peripheral bloodallogeneicacute lymphoblastic leukemiahematology2020standard therapyPoland14
1979peripheral bloodallogeneicnon-Hodgkin lymphomahematology2020standard therapyUSA58
1980peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyItaly58
1981peripheral bloodallogeneicacute lymphoblastic leukemiahematology2020standard therapyUSA59
1982peripheral bloodallogeneicacute lymphoblastic leukemiahematology2020standard therapyUSA60
1983peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyUSA73
1984peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyUSA27
1985peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyAustralia29
1986peripheral bloodallogeneicmyelodysplastic syndromehematology2020standard therapyCroatia55
1987peripheral bloodallogeneicmyelodysplastic syndromehematology2020standard therapyGermany70
1988peripheral bloodallogeneicprimary myelofibrosihematology2020standard therapyPoland63
1989peripheral bloodallogeneicmyelodysplastic syndromehematology2020standard therapyGermany66
1990peripheral bloodallogeneicacute myelogenous leukemia with myelodysplastic syndromehematology2020standard therapyUnited Kingdom64
1991peripheral bloodallogeneicacute lymphoblastic leukemiahematology2020standard therapySwitzerland9
1992peripheral bloodallogeneicprimary myelofibrosihematology2020standard therapyPoland61
1993peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyPoland52
1994peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyGermany58
1995peripheral bloodallogeneicmyelodysplastic syndromehematology2020standard therapyGermany51
1996peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyCanada43
1997peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyPoland67
1998peripheral bloodallogeneicchronic myeloid leukemiahematology2020standard therapyUSA56
1999peripheral bloodallogeneicmyelodysplastic syndromehematology2020standard therapyUSA56
2000peripheral bloodallogeneicsevere aplastic anaemiahematology2020standard therapyBrazil9
2001peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyUSA61
2002peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapySpain63
2003peripheral bloodallogeneicdiffuse large B-cell lymphomahematology2020standard therapyDenmark63
2004peripheral bloodallogeneicacute lymphoblastic leukemiahematology2020standard therapyPoland23
2005peripheral bloodallogeneicmyeloma multiplexhematology2020standard therapyPoland63
2006peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyUSA66
2007peripheral bloodallogeneicmyelodysplastic syndromehematology2020standard therapyUnited Kingdom64
2008peripheral bloodallogeneicmyelodysplastic syndromehematology2020standard therapyUSA31
2009peripheral bloodallogeneicFanconi anaemiahematology2020standard therapyPoland1
2010peripheral bloodallogeneicacute lymphoblastic leukemiahematology2020standard therapyGermany40
2011peripheral bloodallogeneicnon-Hodgkin lymphomahematology2020standard therapyPoland63
2012peripheral bloodallogeneicmyelodysplastic syndromehematology2020standard therapyUSA63
2013peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyUSA60
2014peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyItaly32
2015peripheral bloodallogeneicErdheim Chester diseasehematology2020standard therapyPoland4
2016peripheral bloodallogeneicanaplastic large cell lymphomahematology2020standard therapyPoland8
2017peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyPoland66
2018peripheral bloodallogeneicHodgkin’s lymphomahematology2020standard therapyGermany35
2019peripheral bloodallogeneicB-cell acute lymphoblastic leukemiahematology2020standard therapyGermany29
2020peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyUSA44
2021peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyBelgium40
2022peripheral bloodallogeneicacute myelogenous leukemiahematology2020standard therapyUSA63
2023peripheral bloodallogeneicsecondary acute myelogenous leukemiahematology2020standard therapyGermany76
2024peripheral bloodallogeneicchronic lymphocytic leukemiahematology2020standard therapyAustralia74
2025peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany63
2026peripheral bloodallogeneicsevere aplastic anaemiahematology2019standard therapyChile12
2027peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyCzech Republic65
2028peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyTurkey39
2029peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany53
2030peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA66
2031peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland62
2032peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany37
2033peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyBelgium62
2034peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland54
2035peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland36
2036peripheral bloodallogeneicchronic lymphocytic leukemiahematology2019standard therapyUSA58
2037peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA55
2038peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyTurkey4
2039peripheral bloodallogeneicchronic lymphocytic leukemiahematology2019standard therapyUSA65
2040peripheral bloodallogeneicno datahematology2019standard therapyPoland43
2041peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany53
2042peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyPoland62
2043peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2019standard therapyTurkey54
2044peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyAustralia57
2045peripheral bloodallogeneicmyeloma multiplexhematology2019standard therapyFinland48
2046peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyIreland38
2047peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany59
2048peripheral bloodallogeneicmantle cell lymphomahematology2019standard therapyPoland62
2049peripheral bloodallogeneicmyelofibrosis with myeloid metaplasiahematology2019standard therapyUSA66
2050peripheral bloodallogeneicmycosis fungoidehematology2019standard therapyFinland52
2051peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany57
2052peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUnited Kingdom67
2053peripheral bloodallogeneicmixed phenotype acute leukemiahematology2019standard therapyGermany59
2054peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA69
2055peripheral bloodallogeneicparoxysmal nocturnal hemoglobinuriahematology2019standard therapyPoland24
2056peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyPoland27
2057peripheral bloodallogeneicosteomielofibrosis - otherhematology2019standard therapyUSA63
2058peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyArgentina60
2059peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyBulgaria47
2060peripheral bloodallogeneicprimary immunodeficiencyhematology2019standard therapyUnited Kingdom21
2061peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyGermany14
2062peripheral bloodallogeneicchronic myeloid leukemiahematology2019standard therapyUnited Kingdom23
2063peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyFrance70
2064peripheral bloodallogeneicmyelofibrosis with myeloid metaplasiahematology2019standard therapyUSA69
2065peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapySwitzerland55
2066peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA49
2067peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyUSA67
2068peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyFrance61
2069peripheral bloodallogeneicnon-Hodgkin lymphomahematology2019standard therapyGermany68
2070peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA60
2071peripheral bloodallogeneicchronic myeloid leukemiahematology2019standard therapyUnited Kingdom34
2072peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA60
2073peripheral bloodallogeneicmyeloma multiplexhematology2019standard therapyItaly56
2074peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2019standard therapyDenmark65
2075peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyFrance62
2076peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA29
2077peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyUSA65
2078peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUnited Kingdom60
2079peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyGermany61
2080peripheral bloodallogeneicnon-Hodgkin lymphomahematology2019standard therapyPoland28
2081peripheral bloodallogeneicT-cell acute lymphoblastic leukemiahematology2019standard therapyGermany44
2082peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA75
2083peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyArgentina45
2084peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyFrance52
2085peripheral bloodallogeneicmyelofibrosis with myeloid metaplasiahematology2019standard therapyUSA63
2086peripheral bloodallogeneicno datahematology2019standard therapyGermany66
2087peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany69
2088peripheral bloodallogeneicWiskott-Aldrich syndromehematology2019standard therapyPoland1
2089peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyPoland63
2090peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyGermany70
2091peripheral bloodallogeneicmyelofibrosihematology2019standard therapyUnited Kingdom46
2092peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA72
2093peripheral bloodallogeneicsevere aplastic anaemiahematology2019standard therapyTurkey11
2094peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland37
2095peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyItaly56
2096peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany72
2097peripheral bloodallogeneicGlanzmann thrombastheniahematology2019standard therapyGermany11
2098peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyGermany69
2099peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyRomania18
2100peripheral bloodallogeneichigh risk myelodysplastic syndromehematology2019standard therapyItaly61
2101peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyIran45
2102peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland45
2103peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany62
2104peripheral bloodallogeneicchronic lymphocytic leukemiahematology2019standard therapyUSA69
2105peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyPoland45
2106peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyHungary40
2107peripheral bloodallogeneicmyelofibrosihematology2019standard therapyItaly60
2108peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyUSA20
2109peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA65
2110peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyGermany15
2111peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA72
2112peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA73
2113peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUnited Kingdom50
2114peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyAustralia59
2115peripheral bloodallogeneicmyeloma multiplexhematology2019standard therapyItaly45
2116peripheral bloodallogeneicno datahematology2019standard therapyGermany20
2117peripheral bloodallogeneicextracranial malignant germ cell tumorhematology2019standard therapyUSA53
2118peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland54
2119peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyNetherland66
2120peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA61
2121peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyCroatia55
2122peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland60
2123peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapySwitzerland58
2124peripheral bloodallogeneicchronic myeloid leukemiahematology2019standard therapyItaly37
2125peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyHungary43
2126peripheral bloodallogeneicB-cell acute lymphoblastic leukemiahematology2019standard therapyGermany8
2127peripheral bloodallogeneicother myleofibrosihematology2019standard therapyUSA70
2128peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyTurkey42
2129peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA68
2130peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA65
2131peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyNetherland42
2132peripheral bloodallogeneicother myleofibrosihematology2019standard therapyUSA61
2133peripheral bloodallogeneicHodgkin’s lymphomahematology2019standard therapyPoland65
2134peripheral bloodallogeneicprimary myelofibrosihematology2019standard therapyTurkey46
2135peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland65
2136peripheral bloodallogeneicHodgkin’s lymphomahematology2019standard therapyUSA58
2137peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyFrance72
2138peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA59
2139peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA52
2140peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyCzech Republic29
2141peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyTurkey56
2142peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany29
2143peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA53
2144peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA68
2145peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA62
2146peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA61
2147peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA63
2148peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyPoland51
2149peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyGermany62
2150peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyTurkey7
2151peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyGreece64
2152peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyHungary42
2153peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA70
2154peripheral bloodallogeneicchronic granulomatous diseasehematology2019standard therapyGermany2
2155peripheral bloodallogeneichistiocytosis Xhematology2019standard therapyUSA14
2156peripheral bloodallogeneicprimary mediastinalhematology2019standard therapyPoland33
2157peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA68
2158peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland54
2159peripheral bloodallogeneicmyelodysplastic syndrome - RAEBhematology2019standard therapyBelaru21
2160peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA69
2161peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2019standard therapyUnited Kingdom73
2162peripheral bloodallogeneicβ - thalassemiahematology2019standard therapyRussia13
2163peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany70
2164peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyPoland61
2165peripheral bloodallogeneicmucopolysaccharidosis type Imetabolic2019standard therapyTurkey1
2166peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyCzech Republic64
2167peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapySweden59
2168peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUnited Kingdom68
2169peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany64
2170peripheral bloodallogeneicchronic myeloid leukemiahematology2019standard therapyUSA56
2171peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUnited Kingdom55
2172peripheral bloodallogeneicplasma cell leukemiahematology2019standard therapyPoland35
2173peripheral bloodallogeneicnon-Hodgkin lymphomahematology2019standard therapyItaly58
2174peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyBelgium58
2175peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA48
2176peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA38
2177peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany61
2178peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyItaly65
2179peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyIndia45
2180peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyItaly51
2181peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA62
2182peripheral bloodallogeneicmyelofibrosihematology2019standard therapyCanada62
2183peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyItaly46
2184peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland68
2185peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapySweden66
2186peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyEstonia67
2187peripheral bloodallogeneicchronic lymphocytic leukemiahematology2019standard therapyUSA65
2188peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyUSA48
2189peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany69
2190peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA66
2191peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland65
2192peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2019standard therapyUSA62
2193peripheral bloodallogeneicAPDShematology2019standard therapyGermany20
2194peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyItaly60
2195peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapySlovakia11
2196peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany57
2197peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA67
2198peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyTurkey4
2199peripheral bloodallogeneicHodgkin’s lymphomahematology2019standard therapyUSA28
2200peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany64
2201peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany64
2202peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUruguay40
2203peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA56
2204peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyNetherland63
2205peripheral bloodallogeneicmixed phenotype acute leukemiahematology2019standard therapyPoland49
2206peripheral bloodallogeneicchronic lymphocytic leukemiahematology2019standard therapyUSA60
2207peripheral bloodallogeneicthalassemia majorhematology2019standard therapyIran20
2208peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyIsrael25
2209peripheral bloodallogeneicmyelofibrosihematology2019standard therapyFrance47
2210peripheral bloodallogeneicno datahematology2019standard therapyBelgium58
2211peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA63
2212peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyTurkey44
2213peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyAustralia65
2214peripheral bloodallogeneicmyelofibrosihematology2019standard therapyCanada33
2215peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany60
2216peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyUSA28
2217peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany67
2218peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyGermany66
2219peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyGermany62
2220peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyGermany61
2221peripheral bloodallogeneicmucopolysaccharidosis type IImetabolic2019standard therapyGermany2
2222peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyCanada38
2223peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany67
2224peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapySweden52
2225peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyCzech Republic29
2226peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA23
2227peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUnited Kingdom61
2228peripheral bloodallogeneicmantle cell lymphomahematology2019standard therapyCzech Republic69
2229peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapySlovakia27
2230peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA63
2231peripheral bloodallogeneicmyelodysplastic syndrome - RAEBhematology2019standard therapyPoland16
2232peripheral bloodallogeneicnon-Hodgkin lymphomahematology2019standard therapyPoland67
2233peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyUSA36
2234peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany69
2235peripheral bloodallogeneicchronic granulomatous diseasehematology2019standard therapyUSA16
2236peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyBelgium62
2237peripheral bloodallogeneicmyelofibrosihematology2019standard therapyPoland45
2238peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA61
2239peripheral bloodallogeneicchronic lymphocytic leukemiahematology2019standard therapyCanada69
2240peripheral bloodallogeneicmyelofibrosis with myeloid metaplasiahematology2019standard therapyUSA61
2241peripheral bloodallogeneicprimary immunodeficiencyhematology2019standard therapyRussia19
2242peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyItaly58
2243peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapySlovakia44
2244peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA52
2245peripheral bloodallogeneictrombastenia Glanzmannahematology2019standard therapyGermany11
2246peripheral bloodallogeneicmantle cell lymphomahematology2019standard therapyUSA65
2247peripheral bloodallogeneicnon-Hodgkin lymphomahematology2019standard therapyGermany51
2248peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyNorway45
2249peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapySwitzerland58
2250peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA58
2251peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyCanada36
2252peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyBrazil33
2253peripheral bloodallogeneicmycosis fungoidehematology2019standard therapyAustralia55
2254peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA72
2255peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA61
2256peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA66
2257peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyLithuania67
2258peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapySlovakia58
2259peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA64
2260peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA72
2261peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA65
2262peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland62
2263peripheral bloodallogeneicnon-Hodgkin lymphomahematology2019standard therapyCroatia65
2264peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA62
2265peripheral bloodallogeneicaplasiahematology2019standard therapyUnited Kingdom51
2266peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyCzech Republic23
2267peripheral bloodallogeneicchronic granulomatous diseasehematology2019standard therapyPoland3
2268peripheral bloodallogeneicchronic myeloid leukemiahematology2019standard therapyGreece58
2269peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUnited Kingdom55
2270peripheral bloodallogeneicnon-Hodgkin lymphomahematology2019standard therapyBelgium58
2271peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA5
2272peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany68
2273peripheral bloodallogeneicchronic myeloid leukemiahematology2019standard therapyBelgium56
2274peripheral bloodallogeneicsevere aplastic anaemiahematology2019standard therapyPoland55
2275peripheral bloodallogeneicchronic myeloid leukemiahematology2019standard therapyPoland31
2276peripheral bloodallogeneicmyeloma multiplexhematology2019standard therapyPoland62
2277peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyTurkey15
2278peripheral bloodallogeneicaplastic anaemiahematology2019standard therapyLithuania16
2279peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA49
2280peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyPoland49
2281peripheral bloodallogeneicrelapsed peripheral T cell lymphomahematology2019standard therapyUnited Kingdom65
2282peripheral bloodallogeneicmucopolysaccharidosis type IImetabolic2019standard therapyGermany2
2283peripheral bloodallogeneicchronic myeloid leukemiahematology2019standard therapyBelgium54
2284peripheral bloodallogeneicmyelofibrosihematology2019standard therapyFrance43
2285peripheral bloodallogeneicHodgkin’s lymphomahematology2019standard therapyPoland44
2286peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyCzech Republic59
2287peripheral bloodallogeneicHodgkin’s lymphomahematology2019standard therapyPoland1
2288peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA49
2289peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA49
2290peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyFrance72
2291peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyFrance14
2292peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA23
2293peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPortugal39
2294peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyGermany69
2295peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland25
2296peripheral bloodallogeneicsevere combined immunodeficiencyhematology2019standard therapyPoland1
2297peripheral bloodallogeneicnon-Hodgkin lymphomahematology2019standard therapyUSA42
2298peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyNetherland42
2299peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyGermany78
2300peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA71
2301peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany25
2302peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyItaly72
2303peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUnited Kingdom71
2304peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyBelgium48
2305peripheral bloodallogeneicB-cell chronic lymphoblastic leukemiahematology2019standard therapyGermany66
2306peripheral bloodallogeneicprimary myelofibrosihematology2019standard therapySwitzerland45
2307peripheral bloodallogeneicchronic myeloid leukemiahematology2019standard therapyItaly46
2308peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA45
2309peripheral bloodallogeneicsecondary acute myelogenous leukemiahematology2019standard therapyGermany59
2310peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUnited Kingdom58
2311peripheral bloodallogeneicother myleofibrosihematology2019standard therapyUSA50
2312peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyFrance61
2313peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland64
2314peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyAustria63
2315peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyUSA31
2316peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyCroatia57
2317peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyPoland3
2318peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyFrance29
2319peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany72
2320peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyPoland25
2321peripheral bloodallogeneicacute myelogenous leukemiahematology2019standard therapyGermany46
2322peripheral bloodallogeneicacute lymphoblastic leukemiahematology2019standard therapyCanada43
2323peripheral bloodallogeneicsecondary acute myelogenous leukemiahematology2019standard therapyGermany27
2324peripheral bloodallogeneicnon-Hodgkin lymphomahematology2019standard therapyUSA55
2325peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyFrance42
2326peripheral bloodallogeneicmyelofibrosis with myeloid metaplasiahematology2019standard therapyUSA61
2327peripheral bloodallogeneicHodgkin’s lymphomahematology2019standard therapyUnited Kingdom32
2328peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUnited Kingdom46
2329peripheral bloodallogeneicHodgkin’s lymphomahematology2019standard therapyGermany34
2330peripheral bloodallogeneicmyelodysplastic syndromehematology2019standard therapyUSA65
2331peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA26
2332peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany35
2333peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyCanada59
2334peripheral bloodallogeneicmyelofibrosihematology2018standard therapyNetherland49
2335peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUnited Kingdom29
2336peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUnited Kingdom42
2337peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA74
2338peripheral bloodallogeneicsevere aplastic anaemiahematology2018standard therapyGermany18
2339peripheral bloodallogeneicT-cell acute lymphoblastic leukemiahematology2018standard therapyGermany7
2340peripheral bloodallogeneicmyeloma multiplexhematology2018standard therapyLithuania56
2341peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA63
2342peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUnited Kingdom46
2343peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyPoland23
2344peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland66
2345peripheral bloodallogeneicother myleofibrosihematology2018standard therapyPoland57
2346peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyItaly65
2347peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyPoland48
2348peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyFrance46
2349peripheral bloodallogeneicsecondary acute myelogenous leukemiahematology2018standard therapyPoland58
2350peripheral bloodallogeneicacute myeloid leukemia in first complete remissionhematology2018standard therapyGermany61
2351peripheral bloodallogeneicHodgkin’s lymphomahematology2018standard therapyPoland38
2352peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapySpain34
2353peripheral bloodallogeneicmyelofibrosihematology2018standard therapyGermany60
2354peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA72
2355peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyFrance50
2356peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyFrance33
2357peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA61
2358peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA45
2359peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA45
2360peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyItaly67
2361peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland30
2362peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland71
2363peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA42
2364peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyNetherland67
2365peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany56
2366peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA54
2367peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA72
2368peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland59
2369peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany61
2370peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland51
2371peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany64
2372peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany61
2373peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA50
2374peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA47
2375peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland64
2376peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyItaly62
2377peripheral bloodallogeneicB-cell acute lymphoblastic leukemiahematology2018standard therapyGermany41
2378peripheral bloodallogeneicT-cell acute lymphoblastic leukemiahematology2018standard therapyPoland13
2379peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA68
2380peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA62
2381peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA8
2382peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA54
2383peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland67
2384peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUnited Kingdom22
2385peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapySlovenia54
2386peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany64
2387peripheral bloodallogeneicmyeloma multiplexhematology2018standard therapyUSA57
2388peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyItaly61
2389peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA46
2390peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA76
2391peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyPoland50
2392peripheral bloodallogeneicprimary myelofibrosi, secondary acute myelogenous leukemiahematology2018standard therapyGermany53
2393peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland64
2394peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany38
2395peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyGermany8
2396peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA58
2397peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyGermany77
2398peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyUSA69
2399peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyCanada23
2400peripheral bloodallogeneicB-cell acute lymphoblastic leukemiahematology2018standard therapySwitzerland50
2401peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyUSA70
2402peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA60
2403peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA71
2404peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2018standard therapyUSA39
2405peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyFrance25
2406peripheral bloodallogeneicmyelofibrosihematology2018standard therapySweden56
2407peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapySweden60
2408peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyGermany17
2409peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyUSA31
2410peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2018standard therapyUSA63
2411peripheral bloodallogeneicFanconi anaemiahematology2018standard therapyUSA9
2412peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyPoland49
2413peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland28
2414peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyBelgium68
2415peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA66
2416peripheral bloodallogeneicleukemiahematology2018standard therapyGermany34
2417peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUnited Kingdom37
2418peripheral bloodallogeneicmyelodysplastic syndrome, acute myelogenous leukemiahematology2018standard therapyUSA74
2419peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany65
2420peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyCroatia59
2421peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland60
2422peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany60
2423peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA33
2424peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany67
2425peripheral bloodallogeneicsevere combined immunodeficiencyhematology2018standard therapyTurkey9
2426peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA73
2427peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA68
2428peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany67
2429peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyGermany20
2430peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyLithuania39
2431peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany52
2432peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA66
2433peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyTurkey27
2434peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA57
2435peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland35
2436peripheral bloodallogeneicno datahematology2018standard therapyPoland69
2437peripheral bloodallogeneicdiffuse large B-cell lymphomahematology2018standard therapyPoland54
2438peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland33
2439peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany54
2440peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyItaly8
2441peripheral bloodallogeneicmyeloma multiplexhematology2018standard therapyItaly55
2442peripheral bloodallogeneicno datahematology2018standard therapyFrance70
2443peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyItaly3
2444peripheral bloodallogeneicno datahematology2018standard therapyBelgium70
2445peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyFrance42
2446peripheral bloodallogeneicblastic NK cell lymphomahematology2018standard therapyGermany65
2447peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA62
2448peripheral bloodallogeneicmyeloma multiplexhematology2018standard therapyGermany57
2449peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyArgentina1
2450peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyGermany56
2451peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyBelgium32
2452peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA63
2453peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyGermany63
2454peripheral bloodallogeneicno datahematology2018standard therapyGermany38
2455peripheral bloodallogeneicmyelofibrosihematology2018standard therapyCanada58
2456peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyHungary42
2457peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA72
2458peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland55
2459peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyBrazil71
2460peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA61
2461peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyRussia33
2462peripheral bloodallogeneicplasma cell disorderhematology2018standard therapyFrance64
2463peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA70
2464peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyFrance40
2465peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyBulgaria61
2466peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany58
2467peripheral bloodallogeneicno datahematology2018standard therapyBrazil3
2468peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyGermany27
2469peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyBrazil39
2470peripheral bloodallogeneicsevere aplastic anaemiahematology2018standard therapyUSA74
2471peripheral bloodallogeneicT-cell acute lymphoblastic leukemiahematology2018standard therapyGermany45
2472peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapySpain53
2473peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland70
2474peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyPoland33
2475peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany67
2476peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyLithuania21
2477peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA59
2478peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyNetherland66
2479peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapySerbia39
2480peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2018standard therapyNetherland56
2481peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA39
2482peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyBelgium27
2483peripheral bloodallogeneicsevere aplastic anaemiahematology2018standard therapyPoland24
2484peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland54
2485peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyUSA17
2486peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA50
2487peripheral bloodallogeneicfollicular lymphomahematology2018standard therapyLithuania44
2488peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyPoland7/12
2489peripheral bloodallogeneicchronic myeloid leukemiahematology2018standard therapySweden63
2490peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland31
2491peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA71
2492peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyGermany25
2493peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany46
2494peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyTurkey60
2495peripheral bloodallogeneicchronic lymphocytic leukemiahematology2018standard therapyPoland49
2496peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland32
2497peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyItaly58
2498peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland59
2499peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland38
2500peripheral bloodallogeneicmyelofibrosihematology2018standard therapyBelgium64
2501peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2018standard therapyPoland71
2502peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA64
2503peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapySweden60
2504peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyAustria45
2505peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyIsrael32
2506peripheral bloodallogeneicother myelodysplastic syndromehematology2018standard therapyUSA67
2507peripheral bloodallogeneicsevere aplastic anaemiahematology2018standard therapyUSA70
2508peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany71
2509peripheral bloodallogeneicno datahematology2018standard therapyCzech Republic22
2510peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA63
2511peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyDenmark59
2512peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland69
2513peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA67
2514peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyFrance28
2515peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyCanada63
2516peripheral bloodallogeneicchronic lymphocytic leukemiahematology2018standard therapyItaly38
2517peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyCanada52
2518peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA71
2519peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA62
2520peripheral bloodallogeneicrelapsed peripheral T cell lymphomahematology2018standard therapyCanada44
2521peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUnited Kingdom55
2522peripheral bloodallogeneicprimary immunodeficiencyhematology2018standard therapyRussia3
2523peripheral bloodallogeneicno datahematology2018standard therapyGermany64
2524peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyCanada46
2525peripheral bloodallogeneicchronic myeloid leukemiahematology2018standard therapyUSA48
2526peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany47
2527peripheral bloodallogeneicother malignancyhematology2018standard therapyItaly59
2528peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland29
2529peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUnited Kingdom37
2530peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA36
2531peripheral bloodallogeneicmyelofibrosihematology2018standard therapyUSA68
2532peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA67
2533peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland57
2534peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyUSA65
2535peripheral bloodallogeneicno datahematology2018standard therapyGermany60
2536peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany6
2537peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyUSA49
2538peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland66
2539peripheral bloodallogeneicchronic granulomatous diseasehematology2018standard therapyUSA15
2540peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany56
2541peripheral bloodallogeneicsevere aplastic anaemiahematology2018standard therapyRussia6
2542peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyPoland20
2543peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyPoland48
2544peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyUSA71
2545peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyNetherland31
2546peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyItaly44
2547peripheral bloodallogeneicthalassemia majorhematology2018standard therapyGermany5
2548peripheral bloodallogeneicfollicular lymphoma (non-Hodgkin lymphoma)hematology2018standard therapyCzech Republic56
2549peripheral bloodallogeneicchronic myeloid leukemiahematology2018standard therapyUSA25
2550peripheral bloodallogeneicnon-Hodgkin lymphomahematology2018standard therapyGermany11
2551peripheral bloodallogeneictherapy-related myelodysplastic syndromehematology2018standard therapyGermany65
2552peripheral bloodallogeneicacute lymphoblastic leukemiahematology2018standard therapyGermany59
2553peripheral bloodallogeneicmyelodysplastic syndromehematology2018standard therapyCanada60
2554peripheral bloodallogeneicchronic myelomonocytic leukaemiahematology2018standard therapySpain51
2555peripheral bloodallogeneicmyeloproliferative neoplasmhematology2018standard therapyGermany61
2556peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyGermany58
2557peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapyPoland45
2558peripheral bloodallogeneicacute myelogenous leukemiahematology2018standard therapy